1
|
Reimann R, Barreto B, Romano F, Medeiros J, Camargo BC, N da Silva J, Soares ALB, F de Souza M, Macedo JM, Kayano AM, Zuliani JP, N de Oliveira A, L da Silva S, Diniz-Sousa R, Soares AM. Biomedical and Biotechnological Potential of Animal Venoms: Bothrops Snake Venoms and their Antimicrobial Applications. Curr Med Chem 2024; 31:CMC-EPUB-140020. [PMID: 38676530 DOI: 10.2174/0109298673290981240416070550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Revised: 03/11/2024] [Accepted: 03/18/2024] [Indexed: 04/29/2024]
Abstract
The pursuit of novel treatment alternatives to address the accumulated resistance to antimicrobials over the years has prompted the scientific community to explore biodiversity, particularly animal venom, as a potential source of new antimicrobial drugs. Snake venoms, with their complex mixtures of components, are particularly promising targets for investigation in this regard. The search for novel molecules exhibiting antimicrobial activity against multidrug-resistant strains is of paramount importance for public health and numerous research groups worldwide. High expectations within the healthcare field are supported by the scientific literature, which highlights the potential development of innovative drugs through in vivo and in vitro application, depending on dose titration. Snake venoms and their molecules and peptides offer exponential possibilities for biotechnological applications as antimicrobial agents. However, many uncertainties and unexplored avenues remain, presenting opportunities for discoveries and research.
Collapse
Affiliation(s)
- Raissa Reimann
- Curso de Medicina, Centro Universitário São Lucas, SÃO LUCAS PVH, Porto Velho-RO, Brazil
| | - Breno Barreto
- Curso de Medicina, Centro Universitário São Lucas, SÃO LUCAS PVH, Porto Velho-RO, Brazil
| | - Filippo Romano
- Curso de Medicina, Centro Universitário São Lucas, SÃO LUCAS PVH, Porto Velho-RO, Brazil
| | - Jade Medeiros
- Curso de Medicina, Centro Universitário São Lucas, SÃO LUCAS PVH, Porto Velho-RO, Brazil
| | - Bruna C Camargo
- Curso de Medicina, Centro Universitário São Lucas, SÃO LUCAS PVH, Porto Velho-RO, Brazil
| | - Josiel N da Silva
- Curso de Medicina, Centro Universitário São Lucas, SÃO LUCAS PVH, Porto Velho-RO, Brazil
| | - Ana Luiza B Soares
- Curso de Medicina, Centro Universitário São Lucas, SÃO LUCAS PVH, Porto Velho-RO, Brazil
| | - Mateus F de Souza
- Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia, Porto Velho-RO, Brazil
- Rede de Pesquisa e Conhecimento de Excelência na Amazônia Ocidental, RED-CONEXAO, Brazil
| | - Jamile M Macedo
- Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia, Porto Velho-RO, Brazil
- Rede de Pesquisa e Conhecimento de Excelência na Amazônia Ocidental, RED-CONEXAO, Brazil
| | - Anderson M Kayano
- Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia, Porto Velho-RO, Brazil
- Rede de Pesquisa e Conhecimento de Excelência na Amazônia Ocidental, RED-CONEXAO, Brazil
- Centro de Medicina Tropical, CEPEM, SESAU-RO, Porto Velho-RO, Brazil
| | - Juliana P Zuliani
- Rede de Pesquisa e Conhecimento de Excelência na Amazônia Ocidental, RED-CONEXAO, Brazil
| | - Ana N de Oliveira
- Rede de Pesquisa e Conhecimento de Excelência na Amazônia Ocidental, RED-CONEXAO, Brazil
| | - Saulo L da Silva
- Rede de Pesquisa e Conhecimento de Excelência na Amazônia Ocidental, RED-CONEXAO, Brazil
- LAQV/Requimte, University of Porto, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal
| | - Rafaela Diniz-Sousa
- Curso de Medicina, Centro Universitário São Lucas, SÃO LUCAS PVH, Porto Velho-RO, Brazil
- Rede de Pesquisa e Conhecimento de Excelência na Amazônia Ocidental, RED-CONEXAO, Brazil
| | - Andreimar M Soares
- Curso de Medicina, Centro Universitário São Lucas, SÃO LUCAS PVH, Porto Velho-RO, Brazil
- Fundação Oswaldo Cruz, FIOCRUZ, Fiocruz Rondônia, Porto Velho-RO, Brazil
- Rede de Pesquisa e Conhecimento de Excelência na Amazônia Ocidental, RED-CONEXAO, Brazil
- Rede de Pesquisa e Conhecimento de Excelência na Amazônia Ocidental, RED-CONEXAO, Brazil
| |
Collapse
|
2
|
Serrath SN, Pontes AS, Paloschi MV, Silva MDS, Lopes JA, Boeno CN, Silva CP, Santana HM, Cardozo DG, Ugarte AVE, Magalhães JGS, Cruz LF, Setubal SS, Soares AM, Cavecci-Mendonça B, Santos LD, Zuliani JP. Exosome Liberation by Human Neutrophils under L-Amino Acid Oxidase of Calloselasma rhodostoma Venom Action. Toxins (Basel) 2023; 15:625. [PMID: 37999488 PMCID: PMC10674320 DOI: 10.3390/toxins15110625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Revised: 09/20/2023] [Accepted: 10/17/2023] [Indexed: 11/25/2023] Open
Abstract
L-Amino acid oxidase (LAAO) is an enzyme found in snake venom that has multifaceted effects, including the generation of hydrogen peroxide (H2O2) during oxidative reactions, leading to various biological and pharmacological outcomes such as apoptosis, cytotoxicity, modulation of platelet aggregation, hemorrhage, and neutrophil activation. Human neutrophils respond to LAAO by enhancing chemotaxis, and phagocytosis, and releasing reactive oxygen species (ROS) and pro-inflammatory mediators. Exosomes cellular nanovesicles play vital roles in intercellular communication, including immune responses. This study investigates the impact of Calloselasma rhodostoma snake venom-derived LAAO (Cr-LAAO) on human neutrophil exosome release, including activation patterns, exosome formation, and content. Neutrophils isolated from healthy donors were stimulated with Cr-LAAO (100 μg/mL) for 3 h, followed by exosome isolation and analysis. Results show that Cr-LAAO induces the release of exosomes with distinct protein content compared to the negative control. Proteomic analysis reveals proteins related to the regulation of immune responses and blood coagulation. This study uncovers Cr-LAAO's ability to activate human neutrophils, leading to exosome release and facilitating intercellular communication, offering insights into potential therapeutic approaches for inflammatory and immunological disorders.
Collapse
Affiliation(s)
- Suzanne N. Serrath
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Adriana S. Pontes
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Mauro V. Paloschi
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Milena D. S. Silva
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Jéssica A. Lopes
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Charles N. Boeno
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Carolina P. Silva
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Hallison M. Santana
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Daniel G. Cardozo
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Andrey V. E. Ugarte
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - João G. S. Magalhães
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Larissa F. Cruz
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Sulamita S. Setubal
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
| | - Andreimar M. Soares
- Laboratory of Biotechnology of Proteins and Bioactive Compounds Applied to Health (LABIOPROT), National Institute of Science and Technology in Epidemiology of the Occidental Amazonia0 (INCT-EPIAMO), Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Porto Velho 76801-059, RO, Brazil;
| | - Bruna Cavecci-Mendonça
- Biotechonology Institute (IBTEC), São Paulo State University, Botucatu 01049-010, SP, Brazil; (B.C.-M.); (L.D.S.)
| | - Lucilene D. Santos
- Biotechonology Institute (IBTEC), São Paulo State University, Botucatu 01049-010, SP, Brazil; (B.C.-M.); (L.D.S.)
- Graduate Program in Tropical Diseases and Graduate Program in Medical Biotechnology, Botucatu Medical School (FMB), São Paulo State University, Botucatu 18618-687, SP, Brazil
| | - Juliana P. Zuliani
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ-Rondônia, Porto Velho 76812-245, RO, Brazil; (S.N.S.); (A.S.P.); (M.V.P.); (M.D.S.S.); (J.A.L.); (C.N.B.); (C.P.S.); (H.M.S.); (D.G.C.); (A.V.E.U.); (J.G.S.M.); (L.F.C.); (S.S.S.)
- Departamento de Medicina, Universidade Federal de Rondônia, Porto Velho 76801-059, RO, Brazil
| |
Collapse
|
3
|
Nery NM, Santana HM, Rego CMA, Lopes JA, Silva MDS, Ferreira E Ferreira AA, Reis VP, Paloschi MV, Serrath SN, Bastos JSF, Silva CP, Magalhães JGS, Cruz LF, Setubal SS, Zuliani JP. Bothrops jararacussu snake venom decreases CD1d, CD83, and CD86 expression on bone marrow-derived dendritic cells. Immunol Lett 2023; 262:7-17. [PMID: 37634711 DOI: 10.1016/j.imlet.2023.08.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2023] [Revised: 08/22/2023] [Accepted: 08/23/2023] [Indexed: 08/29/2023]
Abstract
This study was designed to characterize mice bone marrow (BM) and bone marrow-derived dendritic cells (BMDC) and to compare the surface markers expression and inflammatory cytokine liberation in response to LPS and Bothrops jararacussu venom (BjV) stimulation. Typical morphology was observed in BM and BMDCs from the 4th up to the 8th day of culture using recombinant mouse GM-CSF and IL-4. A high basal level of MHC-II, CD1d, CD83, CD11c, CD80, and low CD86 was expressed by BM cells. After stimulation with GM-CSF/IL-4 for BMDCs differentiation, the BM cells differentiated into BMDCs presented MHC-II, CD1d, CD83, CD11c, CD86, and CD80 expression on the 4th - 8th day accompanied with high levels of TNF-α liberated. The difference between the surface markers' expression was observed in this time course in which CD1d, CD11c, and CD80 remained in high levels of expression, while MHC-II and CD83 showed moderate expression during the differentiation period. Also, cytokines liberation was monitored over the period of the BMDCs culture, and on the 6th day, low levels of IL-6 and IL-1β were found, while high levels of TNF-α on the 4th and 8th days, both of which contributed to the maturity of the BMDCs. Maturation of DCs with LPS showed significant upregulation of surface markers (MHC-II, CD1d, CD83, CD86, CD80) and pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) liberation. On the other hand, BjV induced a decrease in CD1d, CD11c, CD83, and CD86 expression in mature BMDCs which was not observed when LPS was used to stimulate BMDCs which probably induces impairment in T-cell activation.
Collapse
Affiliation(s)
- N M Nery
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - H M Santana
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - C M A Rego
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - J A Lopes
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - M D S Silva
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - A A Ferreira E Ferreira
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - V P Reis
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - M V Paloschi
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - S N Serrath
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - J S F Bastos
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - C P Silva
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - J G S Magalhães
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - L F Cruz
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - S S Setubal
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - J P Zuliani
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho-RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho-RO, Brazil.
| |
Collapse
|
4
|
Diniz-Sousa R, Silva CCA, Pereira SS, da Silva SL, Fernandes PA, Teixeira LMC, Zuliani JP, Soares AM. Therapeutic applications of snake venoms: An invaluable potential of new drug candidates. Int J Biol Macromol 2023; 238:124357. [PMID: 37028634 DOI: 10.1016/j.ijbiomac.2023.124357] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Revised: 04/01/2023] [Accepted: 04/03/2023] [Indexed: 04/09/2023]
Abstract
Animal venoms and their chemical compounds have aroused both empirical and scientific attention for ages. However, there has been a significant increase in scientific investigations in recent decades, allowing the production of various formulations that are helping in the development of many important tools for biotechnological, diagnostic, or therapeutic use, both in human and animal health, as well as in plants. Venoms are composed of biomolecules and inorganic compounds that may have physiological and pharmacological activities that are not related to their principal actions (prey immobilization, digestion, and defense). Snake venom toxins, mainly enzymatic and non-enzymatic proteins, and peptides have been identified as potential prototypes for new drugs and/or models for the development of pharmacologically active structural domains for the treatment of cancer, cardiovascular diseases, neurodegenerative and autoimmune diseases, pain, and infectious-parasitic diseases. This minireview aims to provide an overview of the biotechnological potential of animal venoms, with a focus on snakes, and to introduce the reader to the fascinating world of Applied Toxinology, where animal biodiversity can be used to develop therapeutic and diagnostic applications for humans.
Collapse
Affiliation(s)
- Rafaela Diniz-Sousa
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos Aplicados à Saúde (LABIOPROT), Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, Rondônia, Brazil; Centro Universitário São Lucas (UniSL), Porto Velho, Rondônia, Brazil
| | - Cleópatra C A Silva
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos Aplicados à Saúde (LABIOPROT), Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, Rondônia, Brazil; Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental (INCT-EpiAmO), Porto Velho, Rondônia, Brazil
| | - Soraya S Pereira
- Laboratório de Engenharia de Anticorpos, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, Rondônia, Brazil
| | - Saulo L da Silva
- LAQV/Requimte, University of Porto, Rua do Campo Alegre s/n, Porto, Portugal; Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Rua do Campo Alegre s/n, Porto, Portugal; Faculty of Chemical Sciences, University of Cuenca, Cuenca, Azuay, Ecuador
| | - Pedro A Fernandes
- LAQV/Requimte, University of Porto, Rua do Campo Alegre s/n, Porto, Portugal; Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Rua do Campo Alegre s/n, Porto, Portugal
| | - Luís M C Teixeira
- LAQV/Requimte, University of Porto, Rua do Campo Alegre s/n, Porto, Portugal; Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Rua do Campo Alegre s/n, Porto, Portugal
| | - Juliana P Zuliani
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, Rondônia, Brazil
| | - Andreimar M Soares
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos Aplicados à Saúde (LABIOPROT), Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, Rondônia, Brazil; Centro Universitário São Lucas (UniSL), Porto Velho, Rondônia, Brazil; Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental (INCT-EpiAmO), Porto Velho, Rondônia, Brazil; Faculdade Católica de Rondônia (FCR), Porto Velho, Rondônia, Brazil.
| |
Collapse
|
5
|
Abstract
Snakebite envenoming is characterized by the injection of a mixture of proteins/toxins present in venom following the bite of a venomous snake. The toxins have potent bioactivity capability to impact different aspects of envenomation evolution. The cascade of immune responses initiated by the participation of venom and/or toxins isolated from snake venom can contribute to the systemic and local inflammatory effects observed in victims of envenomation. To understand envenomation, a deeper comprehension of the numerous cells, mediators, and components that comprise the immune system reaction to the venom components is required. Thus, activities related to the immune response are highlighted in this study, including the initial line of defense of the innate immune response as signals for the complicated reaction led by specialized cells.
Collapse
Affiliation(s)
- Juliana P Zuliani
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.
| |
Collapse
|
6
|
Lopes JA, Boeno CN, Paloschi MV, Silva MDS, Rego CMA, Pires WL, Santana HM, Chaves YO, Rodrigues MMDS, Lima AM, Setúbal SDS, Soares AM, Zuliani JP. Phenotypic, functional and plasticity features of human PBMCs induced by venom secreted PLA 2s. Mol Immunol 2023; 155:135-152. [PMID: 36812762 DOI: 10.1016/j.molimm.2023.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2022] [Revised: 01/27/2023] [Accepted: 02/07/2023] [Indexed: 02/22/2023]
Abstract
Bothrops venom contains a high amount of secreted phospholipase A2 (sPLA2s) enzymes responsible for the inflammatory reaction and activation of leukocytes in cases of envenoming. PLA2s are proteins that have enzymatic activity and can hydrolyze phospholipids at the sn-2 position, thereby releasing fatty acids and lysophospholipids precursors of eicosanoids, which are significant mediators of inflammatory conditions. Whether these enzymes have a role in the activation and function of peripheral blood mononuclear cells (PBMCs) is not known. Here we show for the first time how two secreted PLA2s (BthTX-I and BthTX-II) isolated from the venom of Bothrops jararacussu affect the function and polarization of PBMCs. Neither BthTX-I nor BthTX-II exhibited significant cytotoxicity to isolated PBMCs compared with the control at any of the time points studied. RT-qPCR and enzyme-linked immunosorbent assays were used to determine changes in gene expression and the release of pro-inflammatory (TNF-α, IL-6, and IL-12) and anti-inflammatory (TGF-β and IL-10) cytokines, respectively, during the cell differentiation process. Lipid droplets formation and phagocytosis were also investigated. Monocytes/macrophages were labeled with anti-CD14, -CD163, and -CD206 antibodies to assay cell polarization. Both toxins caused a heterogeneous morphology (M1 and M2) on days 1 and 7 based on immunofluorescence analysis, revealing the considerable flexibility of these cells even in the presence of typical polarization stimuli. Thus, these findings indicate that the two sPLA2s trigger both immune response profiles in PBMCs indicating a significant degree of cell plasticity, which may be crucial for understanding the consequences of snake envenoming.
Collapse
Affiliation(s)
- Jéssica Amaral Lopes
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Charles Nunes Boeno
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Mauro Valentino Paloschi
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Milena Daniela Souza Silva
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Cristina Matiele Alves Rego
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Weverson Luciano Pires
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Hallison Mota Santana
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Yury Oliveira Chaves
- Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil; Fundação Oswaldo Cruz, FIOCRUZ Amazônia, Manaus, AM, Brazil
| | - Moreno Magalhães de Souza Rodrigues
- Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil; Laboratório de Análise e Visualização de Dados, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Anderson M Lima
- Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil; Laboratório de Biotecnologia de Proteínas e Compostos Bioativos, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Brazil
| | - Sulamita da S Setúbal
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Andreimar M Soares
- Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil; Laboratório de Biotecnologia de Proteínas e Compostos Bioativos, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Brazil
| | - Juliana P Zuliani
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil; Laboratório de Biotecnologia de Proteínas e Compostos Bioativos, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Brazil.
| |
Collapse
|
7
|
Boeno CN, Paloschi MV, Lopes JA, Souza Silva MD, Evangelista JR, Dos Reis VP, da S Setúbal S, Soares AM, Zuliani JP. Dynamics of action of a Lys-49 and an Asp-49 PLA 2s on inflammasome NLRP3 activation in murine macrophages. Int Immunopharmacol 2022; 112:109194. [PMID: 36041255 DOI: 10.1016/j.intimp.2022.109194] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2022] [Revised: 08/08/2022] [Accepted: 08/22/2022] [Indexed: 11/30/2022]
Abstract
Phospholipases A2 (PLA2s) are proteins found in snake venoms with hemolytic, anticoagulant, myotoxic, edematogenic, bactericidal and inflammatory actions. In Bothrops jararacussu snake venom were isolated a Lys49-PLA2 (BthTX-I) and an Asp49-PLA2 (BthTX-II) with myotoxic and inflammatory actions. Both PLA2s can activate the NLRP3 inflammasome, an intracytoplasmic platform that recognizes molecules released when tissue is damaged liberating IL-1β that contributes to the inflammatory response observed in envenoming. The dynamic of action of BthTX-I and BthTX-II in both thioglycollate (TG)-elicited macrophages and C2C12 myoblasts and the involvement of EP1 and EP2 receptors, and PGE2 in NLRP3 inflammasome activation were evaluated. Both toxins induced PGE2 liberation and inflammasome components (NLRP3, Caspase-1, ASC, IL-1β, and IL18), IL-6, P2X7, COX-1, COX-2, EP2 and EP4 gene expression in TG-elicited macrophages but not in C2C12 myoblasts. EP2 (PF04418948) and EP4 (GW627368X) inhibitors abolished this effect. Both PLA2s also induced NLRP3 inflammasome protein expression that was abolished with the inhibitors used. Immunofluorescence and IL-1β assays confirmed the NLRP3 activation in TG-elicited macrophages with the participation of both EP2 and EP4 receptors confirming their involvement in this effect. All in all, BthTX-I and BthTX-II activate macrophages and induce the NLRP3 inflammasome complex activation with the participation of the PGE2 via COX pathway and EP2 and EP4, both PGE2 receptors, contributing to the local inflammatory effects observed in envenoming.
Collapse
Affiliation(s)
- Charles N Boeno
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Mauro V Paloschi
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Jéssica A Lopes
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Milena D Souza Silva
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Jaína R Evangelista
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Valdison P Dos Reis
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Sulamita da S Setúbal
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Andreimar M Soares
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Juliana P Zuliani
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.
| |
Collapse
|
8
|
Kwasniewski FH, Kayano AM, Fukunaga AN, da Silva Setubal S, Soares AM, Zuliani JP. Bothrops jararacussu snake venom lectin induces mast cell activation and vascular permeability enhance in an animal model. Toxicon 2021; 205:20-23. [PMID: 34785172 DOI: 10.1016/j.toxicon.2021.11.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2021] [Revised: 11/03/2021] [Accepted: 11/09/2021] [Indexed: 11/19/2022]
Abstract
Bothrops species trigger an acute inflammatory response in victims, with activated leukocytes releasing several mediators that may contribute to local and systemic effects. The effects of BjcuL, a lectin isolated from B. jararacussu snake venom, on mast cells and vasopermeability were investigated in this study. BjcuL activates mast cells and increases vasopermeability through the involvement of histamine and platelet activating factor, which may play a role in the victims' acute inflammatory reaction.
Collapse
Affiliation(s)
- Fábio H Kwasniewski
- Universidade Estadual de Londrina (UEL), Centro de Ciências Biológicas, Departamento de Ciências Patológicas, Londrina, PR, Brazil.
| | - Anderson M Kayano
- Centro de Pesquisa em Medicina Tropical (CEPEM/SESAU-RO), Porto Velho, RO, Brazil; Fundação Oswaldo Cruz-Rondônia (FIOCRUZ-RO), Laboratório de Biotecnologia de Proteínas e Compostos Bioativos, Porto Velho, RO, Brazil; Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental (INCT-EPIAMO), Porto Velho, RO, Brazil
| | | | - Sulamita da Silva Setubal
- Fundação Oswaldo Cruz-Rondônia (FIOCRUZ-RO), Laboratório de Imunologia Celular Aplicada à Saúde, Porto Velho, RO, Brazil
| | - Andreimar Martins Soares
- Fundação Oswaldo Cruz-Rondônia (FIOCRUZ-RO), Laboratório de Biotecnologia de Proteínas e Compostos Bioativos, Porto Velho, RO, Brazil; Instituto Nacional de Ciência e Tecnologia de Epidemiologia da Amazônia Ocidental (INCT-EPIAMO), Porto Velho, RO, Brazil
| | - Juliana P Zuliani
- Fundação Oswaldo Cruz-Rondônia (FIOCRUZ-RO), Laboratório de Imunologia Celular Aplicada à Saúde, Porto Velho, RO, Brazil.
| |
Collapse
|
9
|
Costa TR, Francisco AF, Cardoso FF, Moreira-Dill LS, Fernandes CAH, Gomes AAS, Guimarães CLS, Marcussi S, Pereira PS, Oliveira HC, Fontes MRM, Silva SL, Zuliani JP, Soares AM. Gallic acid anti-myotoxic activity and mechanism of action, a snake venom phospholipase A 2 toxin inhibitor, isolated from the medicinal plant Anacardium humile. Int J Biol Macromol 2021; 185:494-512. [PMID: 34197854 DOI: 10.1016/j.ijbiomac.2021.06.163] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 05/31/2021] [Accepted: 06/24/2021] [Indexed: 11/17/2022]
Abstract
Snakebite envenoming is the cause of an ongoing health crisis in several regions of the world, particularly in tropical and neotropical countries. This scenario creates an urgent necessity for new practical solutions to address the limitations of current therapies. The current study investigated the isolation, phytochemical characterization, and myotoxicity inhibition mechanism of gallic acid (GA), a myotoxin inhibitor obtained from Anacardium humile. The identification and isolation of GA was achieved by employing analytical chromatographic separation, which exhibited a compound with retention time and nuclear magnetic resonance spectra compatible with GA's commercial standard and data from the literature. GA alone was able to inhibit the myotoxic activity induced by the crude venom of Bothrops jararacussu and its two main myotoxins, BthTX-I and BthTX-II. Circular dichroism (CD), fluorescence spectroscopy (FS), dynamic light scattering (DLS), and interaction studies by molecular docking suggested that GA forms a complex with BthTX-I and II. Surface plasmon resonance (SPR) kinetics assays showed that GA has a high affinity for BthTX-I with a KD of 9.146 × 10-7 M. Taken together, the two-state reaction mode of GA binding to BthTX-I, and CD, FS and DLS assays, suggest that GA is able to induce oligomerization and secondary structure changes for BthTX-I and -II. GA and other tannins have been shown to be effective inhibitors of snake venoms' toxic effects, and herein we demonstrated GA's ability to bind to and inhibit a snake venom PLA2, thus proposing a new mechanism of PLA2 inhibition, and presenting more evidence of GA's potential as an antivenom compound.
Collapse
Affiliation(s)
- Tássia R Costa
- Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, UFU, Uberlândia, MG, Brazil
| | - Aleff F Francisco
- Departamento de Biofísica e Farmacologia, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil; Laboratório de Biotecnologia de Proteínas e Compostos Bioativos, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, RO, Brazil
| | - Fábio F Cardoso
- Departamento de Biofísica e Farmacologia, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - Leandro S Moreira-Dill
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, RO, Brazil
| | - Carlos A H Fernandes
- Departamento de Biofísica e Farmacologia, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - Antoniel A S Gomes
- Departamento de Biofísica e Farmacologia, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - César L S Guimarães
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, RO, Brazil; Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renováveis, IBAMA, Porto Velho, RO, Brazil
| | - Silvana Marcussi
- Departamento de Química, Universidade Federal de Lavras, UFLA, Lavras, MG, Brazil
| | | | - Hamine C Oliveira
- Departamento de Biofísica e Farmacologia, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - Marcos R M Fontes
- Departamento de Biofísica e Farmacologia, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - Saulo L Silva
- Faculty of Chemical Sciences, University of Cuenca, Cuenca, Azuay, Ecuador; LAQV/Requimte, Faculty of Sciences University of Porto, Porto, Portugal
| | - Juliana P Zuliani
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, RO, Brazil
| | - Andreimar M Soares
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos, LABIOPROT, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, RO, Brazil; Centro Universitário São Lucas, UniSL, Porto Velho, RO, Brazil; Instituto Nacional de Ciência e Tecnologia em Epidemiologia da Amazônia Ocidental (INCT-EpiAmO), Brazil.
| |
Collapse
|
10
|
Fernandes CFC, Pereira SS, Luiz MB, Silva NKRL, Silva MCS, Marinho ACM, Fonseca MHG, Furtado GP, Trevizani R, Nicolete R, Soares AM, Zuliani JP, Stabeli RG. Engineering of single-domain antibodies for next-generation snakebite antivenoms. Int J Biol Macromol 2021; 185:240-250. [PMID: 34118288 DOI: 10.1016/j.ijbiomac.2021.06.043] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Revised: 06/04/2021] [Accepted: 06/06/2021] [Indexed: 12/29/2022]
Abstract
Given the magnitude of the global snakebite crisis, strategies to ensure the quality of antivenom, as well as the availability and sustainability of its supply are under development by several research groups. Recombinant DNA technology has allowed the engineering of monoclonal antibodies and recombinant fragments as alternatives to conventional antivenoms. Besides having higher therapeutic efficacy, with broad neutralization capacity against local and systemic toxicity, novel antivenoms need to be safe and cost-effective. Due to the biological and physical chemical properties of camelid single-domain antibodies, with high volume of distribution to distal tissue, their modular format, and their versatility, their biotechnological application has grown considerably in recent decades. This article presents the most up-to-date developments concerning camelid single-domain-based antibodies against major toxins from snake venoms, the main venomous animals responsible for reported envenoming cases and related human deaths. A brief discussion on the composition, challenges, and perspectives of antivenoms is presented, as well as the road ahead for next-generation antivenoms based on single-domain antibodies.
Collapse
Affiliation(s)
| | - Soraya S Pereira
- Fundação Oswaldo Cruz, Fiocruz Rondônia, and Instituto Nacional de Ciência e Tecnologia em Epidemiologia da Amazônia Ocidental, INCT-EpiAmO, Porto Velho, Rondônia, Brazil
| | - Marcos B Luiz
- Fundação Oswaldo Cruz, Fiocruz Rondônia, and Instituto Nacional de Ciência e Tecnologia em Epidemiologia da Amazônia Ocidental, INCT-EpiAmO, Porto Velho, Rondônia, Brazil
| | - Nauanny K R L Silva
- Fundação Oswaldo Cruz, Fiocruz Rondônia, and Instituto Nacional de Ciência e Tecnologia em Epidemiologia da Amazônia Ocidental, INCT-EpiAmO, Porto Velho, Rondônia, Brazil
| | - Marcela Cristina S Silva
- Fundação Oswaldo Cruz, Fiocruz Rondônia, and Instituto Nacional de Ciência e Tecnologia em Epidemiologia da Amazônia Ocidental, INCT-EpiAmO, Porto Velho, Rondônia, Brazil
| | | | | | | | | | | | - Andreimar M Soares
- Fundação Oswaldo Cruz, Fiocruz Rondônia, and Instituto Nacional de Ciência e Tecnologia em Epidemiologia da Amazônia Ocidental, INCT-EpiAmO, Porto Velho, Rondônia, Brazil
| | - Juliana P Zuliani
- Fundação Oswaldo Cruz, Fiocruz Rondônia, and Instituto Nacional de Ciência e Tecnologia em Epidemiologia da Amazônia Ocidental, INCT-EpiAmO, Porto Velho, Rondônia, Brazil; Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil
| | - Rodrigo G Stabeli
- Plataforma Bi-Institucional de Medicina Translacional (Fiocruz-USP), Ribeirão Preto, São Paulo, Brazil
| |
Collapse
|
11
|
Reis VP, Rego CMA, Setúbal SS, Tavares MNM, Boeno CN, Ferreira E Ferreira AA, Paloschi MV, Soares AM, Zamuner SR, Zuliani JP. Effect of light emitting diode photobiomodulation on murine macrophage function after Bothrops envenomation. Chem Biol Interact 2020; 333:109347. [PMID: 33259806 DOI: 10.1016/j.cbi.2020.109347] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2020] [Revised: 11/10/2020] [Accepted: 11/26/2020] [Indexed: 11/29/2022]
Abstract
Several reports have suggested that photobiomodulation, owing to its analgesic, anti-inflammatory, and healing effects, may be an effective therapeutic option for local effects of snakebites when the availability and accessibility of conventional serum therapy are inefficient and far from medical care centers. Although there have been studies that demonstrate the application of photobiomodulation in the treatment of local adverse events due to snakebites from snakes of the genus Bothrops, its role in the activation of leukocytes, particularly macrophages, has not been evaluated. Here, we assessed the effect of light-emitting diode (LED) treatment on macrophage activation induced by B. jararacussu venom (BjV). LED treatment caused an increase in the viability of macrophages incubated with BjV. This treatment reduced reactive oxygen species (ROS) and nitric oxide (NO) production by macrophages after incubation with BjV. However, LED treatment did not interfere with IL-1β and IL-10 production by macrophages after incubation with BjV. In conclusion, this study showed that LED treatment has the potential to be used in combination with conventional serum therapy to prevent or minimize the progression of local to severe symptoms after Bothrops envenomation.
Collapse
Affiliation(s)
- Valdison P Reis
- Lab. Imunologia Celular Aplicada à Saúde, FIOCRUZ-Rondônia, Porto Velho, RO, Brazil
| | - Cristina M A Rego
- Lab. Imunologia Celular Aplicada à Saúde, FIOCRUZ-Rondônia, Porto Velho, RO, Brazil
| | - Sulamita S Setúbal
- Lab. Imunologia Celular Aplicada à Saúde, FIOCRUZ-Rondônia, Porto Velho, RO, Brazil
| | | | - Charles N Boeno
- Lab. Imunologia Celular Aplicada à Saúde, FIOCRUZ-Rondônia, Porto Velho, RO, Brazil
| | | | - Mauro V Paloschi
- Lab. Imunologia Celular Aplicada à Saúde, FIOCRUZ-Rondônia, Porto Velho, RO, Brazil
| | - Andreimar M Soares
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Dep. Medicina, Universidade Federal de Rondônia (UNIR) e FIOCRUZ-Rondônia, Porto Velho, RO, Brazil; Centro Universitário São Lucas (UNISL), Porto Velho, RO, Brazil
| | | | - Juliana P Zuliani
- Lab. Imunologia Celular Aplicada à Saúde, FIOCRUZ-Rondônia, Porto Velho, RO, Brazil; Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Dep. Medicina, Universidade Federal de Rondônia (UNIR) e FIOCRUZ-Rondônia, Porto Velho, RO, Brazil.
| |
Collapse
|
12
|
González Rodríguez II, Francisco AF, Moreira-Dill LS, Quintero A, Guimarães CLS, Fernandes CAH, Takeda AAS, Zanchi FB, Caldeira CAS, Pereira PS, Fontes MRM, Zuliani JP, Soares AM. Isolation and structural characterization of bioactive compound from Aristolochia sprucei aqueous extract with anti-myotoxic activity. Toxicon X 2020; 7:100049. [PMID: 32613196 PMCID: PMC7322210 DOI: 10.1016/j.toxcx.2020.100049] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Revised: 06/08/2020] [Accepted: 06/17/2020] [Indexed: 11/26/2022] Open
Abstract
A bioactive compound isolated from the stem extract of Aristolochia sprucei through High Performance Liquid Chromatography (HPLC) was identified via Nuclear Magnetic Resonance (NMR) as the aristolochic acid (AA). This compound showed an inhibitory effect over the myotoxic activity of Bothrops jararacussu and Bothrops asper venoms, being also effective against the indirect hemolytic activity of B. asper venom. Besides, AA also inhibited the myotoxic activity of BthTX-I and MTX-II with an efficiency greater than 60% against both myotoxins. Docking predictions revealed an interesting mechanism, through which the AA displays an interaction profile consistent with its inhibiting abilities, binding to both active and putative sites of svPLA2. Overall, the present findings indicate that AA may bind to critical regions of myotoxic Asp 49 and Lys49-PLA2s from snake venoms, highlighting the relevance of domains comprising the active and putative sites to inhibit these toxins.
Collapse
Affiliation(s)
- Isela I González Rodríguez
- Faculdade de Ciências Farmacêuticas de Ribeirão Preto, FCFRP, Universidade de São Paulo, USP, Ribeirão Preto, SP, Brazil
| | - Aleff F Francisco
- Departamento de Física e Biofísica, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil.,Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Leandro S Moreira-Dill
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Aristides Quintero
- Faculdade de Ciências Farmacêuticas de Ribeirão Preto, FCFRP, Universidade de São Paulo, USP, Ribeirão Preto, SP, Brazil.,Centro de Informaciones e Investigaciones Toxicológicas y Químicas Aplicadas (CEIITOXQUIA) and Departamento de Química, FCNYE, Universidad Autónoma de Chiriquí, UNACHI, David, Panama
| | - César L S Guimarães
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.,Instituto Brasileiro Do Meio Ambiente e Dos Recursos Naturais Renováveis, IBAMA, Porto Velho, RO, Brazil
| | - Carlos A H Fernandes
- Departamento de Física e Biofísica, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - Agnes A S Takeda
- Departamento de Física e Biofísica, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - Fernando B Zanchi
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.,Instituto Nacional de Ciência e Tecnologia Em Epidemiologia da Amazônia Ocidental, INCT - EpiAmO, Brazil
| | - Cléopatra A S Caldeira
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Paulo S Pereira
- Unidade de Biotecnologia, Universidade de Ribeirão Preto, UNAERP, Ribeirão Preto, SP, Brazil.,Instituto Federal de Goiás, IFG, Goiania, GO, Brazil
| | - Marcos R M Fontes
- Departamento de Física e Biofísica, Instituto de Biociências, Universidade Estadual Paulista, UNESP, Botucatu, SP, Brazil
| | - Juliana P Zuliani
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.,Laboratório de Imunologia Celular Aplicada a Saúde, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia, Porto Velho, RO, Brazil
| | - Andreimar M Soares
- Laboratório de Biotecnologia de Proteínas e Compostos Bioativos da Amazônia Ocidental, LaBioProt, Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, FIOCRUZ, Unidade Rondônia e Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.,Centro Universitário São Lucas, UniSL, Porto Velho, RO, Brazil.,Instituto Nacional de Ciência e Tecnologia Em Epidemiologia da Amazônia Ocidental, INCT - EpiAmO, Brazil
| |
Collapse
|
13
|
Setúbal SDS, Pontes AS, Nery NM, Rego CMA, Santana HM, de Lima AM, Boeno CN, Paloschi MV, Soares AM, Zuliani JP. Human neutrophils functionality under effect of an Asp49 phospholipase A 2 isolated from Bothrops atrox venom. Toxicon X 2020; 6:100032. [PMID: 32550587 DOI: 10.1016/j.toxcx.2020.100032] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2019] [Revised: 03/10/2020] [Accepted: 03/12/2020] [Indexed: 12/23/2022] Open
Abstract
Bothrops envenomation is associated with a cellular inflammatory response, characterized by pronounced neutrophil infiltration at the site of injury. Neutrophils act as the first line of defence, owing to their ability to migrate to the infected tissue, promoting an acute inflammatory response. At the site of inflammation, neutrophils perform defence functions such as phagocytosis, release of proteolytic enzymes, generation of reactive oxygen species (ROS), and synthesis of inflammatory mediators such as cytokines and lipid mediators. Neutrophils can also form neutrophil extracellular nets (NETs), webs composed of chromatin and granule proteins. This occurs after neutrophil activation and delivers high concentrations of anti-microbial molecules to the site of injury. This study evaluated the impact of BaTX-II, an Asp49 phospholipase A2 (PLA2) isolated from Bothrops atrox snake venom on human neutrophils in vitro. At non-toxic concentrations, BaTX-II induced hydrogen peroxide production by neutrophils, and this was reduced by wortmannin, a PI3K inhibitor. BaTX-II stimulated IL-1β, IL-8, LTB4, myeloperoxidase (MPO), and DNA content release, consistent with NET formation. This is the first study to show the triggering of relevant pro-inflammatory events by PLA2 Asp49 isolated from secretory venom.
Collapse
Affiliation(s)
- Sulamita da S Setúbal
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz (FIOCRUZ) Rondônia, Porto Velho, RO, Brazil
| | - Adriana S Pontes
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz (FIOCRUZ) Rondônia, Porto Velho, RO, Brazil
| | - Neriane M Nery
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz (FIOCRUZ) Rondônia, Porto Velho, RO, Brazil
| | - Cristina M A Rego
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz (FIOCRUZ) Rondônia, Porto Velho, RO, Brazil
| | - Hallison M Santana
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz (FIOCRUZ) Rondônia, Porto Velho, RO, Brazil
| | - Anderson M de Lima
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, (FIOCRUZ) Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
| | - Charles N Boeno
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz (FIOCRUZ) Rondônia, Porto Velho, RO, Brazil
| | - Mauro V Paloschi
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz (FIOCRUZ) Rondônia, Porto Velho, RO, Brazil
| | - Andreimar M Soares
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, (FIOCRUZ) Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
- Universidade São Lucas (UniSL), Porto Velho, RO, Brazil
| | - Juliana P Zuliani
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz (FIOCRUZ) Rondônia, Porto Velho, RO, Brazil
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, (FIOCRUZ) Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
| |
Collapse
|
14
|
de Medeiros DSS, Rego TB, dos Santos APDA, Pontes AS, Moreira-Dill LS, Matos NB, Zuliani JP, Stábeli RG, Teles CBG, Soares AM, Sperotto ARDM, Moura DJ, Saffi J, Caldeira CADS, Pimenta DC, Calderon LA. Corrigendum to "Biochemical and Biological Profile of Parotoid Secretion of the Amazonian Rhinella marina (Anura: Bufonidae)". Biomed Res Int 2019; 2019:4209743. [PMID: 31263705 PMCID: PMC6556797 DOI: 10.1155/2019/4209743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/30/2019] [Accepted: 05/02/2019] [Indexed: 11/17/2022]
Abstract
[This corrects the article DOI: 10.1155/2019/2492315.].
Collapse
Affiliation(s)
- Daniel S. S. de Medeiros
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fiocruz-Rondônia and Universidade Federal de Rondônia, Porto Velho, 76812-245, Brazil
- Plataforma de Bioensaios de Malária e Leishmaniose (PBML), FIOCRUZ-Rondônia, Porto Velho, 76812-245, Brazil
- Instituto Nacional de Epidemiologia na Amazônia Ocidental, Porto Velho, 76812-245, Brazil
| | - Tiago B. Rego
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fiocruz-Rondônia and Universidade Federal de Rondônia, Porto Velho, 76812-245, Brazil
| | - Ana P. de A. dos Santos
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fiocruz-Rondônia and Universidade Federal de Rondônia, Porto Velho, 76812-245, Brazil
- Plataforma de Bioensaios de Malária e Leishmaniose (PBML), FIOCRUZ-Rondônia, Porto Velho, 76812-245, Brazil
- Instituto Nacional de Epidemiologia na Amazônia Ocidental, Porto Velho, 76812-245, Brazil
| | - Adriana S. Pontes
- Laboratório de Imunologia Aplicada à Saúde, FIOCRUZ-Rondônia, Porto Velho, 76812-245, Brazil
| | - Leandro S. Moreira-Dill
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fiocruz-Rondônia and Universidade Federal de Rondônia, Porto Velho, 76812-245, Brazil
- Instituto Nacional de Epidemiologia na Amazônia Ocidental, Porto Velho, 76812-245, Brazil
| | - Najla B. Matos
- Instituto Nacional de Epidemiologia na Amazônia Ocidental, Porto Velho, 76812-245, Brazil
- Laboratório de Microbiologia, FIOCRUZ-Rondônia, Porto Velho, 76812-245, Brazil
| | - Juliana P. Zuliani
- Instituto Nacional de Epidemiologia na Amazônia Ocidental, Porto Velho, 76812-245, Brazil
- Laboratório de Imunologia Aplicada à Saúde, FIOCRUZ-Rondônia, Porto Velho, 76812-245, Brazil
| | - Rodrigo G. Stábeli
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fiocruz-Rondônia and Universidade Federal de Rondônia, Porto Velho, 76812-245, Brazil
- Instituto Nacional de Epidemiologia na Amazônia Ocidental, Porto Velho, 76812-245, Brazil
| | - Carolina B. G. Teles
- Plataforma de Bioensaios de Malária e Leishmaniose (PBML), FIOCRUZ-Rondônia, Porto Velho, 76812-245, Brazil
- Instituto Nacional de Epidemiologia na Amazônia Ocidental, Porto Velho, 76812-245, Brazil
| | - Andreimar M. Soares
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fiocruz-Rondônia and Universidade Federal de Rondônia, Porto Velho, 76812-245, Brazil
- Instituto Nacional de Epidemiologia na Amazônia Ocidental, Porto Velho, 76812-245, Brazil
| | - Angelo R. de M. Sperotto
- Laboratório de Genética Toxicológica, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, 90050-170, Brazil
| | - Dinara J. Moura
- Laboratório de Genética Toxicológica, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, 90050-170, Brazil
| | - Jenifer Saffi
- Laboratório de Genética Toxicológica, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, 90050-170, Brazil
| | - Cleópatra Alves da Silva Caldeira
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fiocruz-Rondônia and Universidade Federal de Rondônia, Porto Velho, 76812-245, Brazil
| | - Daniel Carvalho Pimenta
- Laboratório de Bioquímica e Biofísica, Instituto Butantan, Avenida Vital Brazil, 1500, 05503-900 Sao Paulo, SP, Brazil
| | - Leonardo A. Calderon
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fiocruz-Rondônia and Universidade Federal de Rondônia, Porto Velho, 76812-245, Brazil
- Instituto Nacional de Epidemiologia na Amazônia Ocidental, Porto Velho, 76812-245, Brazil
| |
Collapse
|
15
|
Bittencourt JAHM, Neto MFA, Lacerda PS, Bittencourt RCVS, Silva RC, Lobato CC, Silva LB, Leite FHA, Zuliani JP, Rosa JMC, Borges RS, Santos CBR. In Silico Evaluation of Ibuprofen and Two Benzoylpropionic Acid Derivatives with Potential Anti-Inflammatory Activity. Molecules 2019; 24:E1476. [PMID: 30991684 PMCID: PMC6515000 DOI: 10.3390/molecules24081476] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2019] [Revised: 04/07/2019] [Accepted: 04/11/2019] [Indexed: 12/19/2022] Open
Abstract
Inflammation is a complex reaction involving cellular and molecular components and an unspecific response to a specific aggression. The use of scientific and technological innovations as a research tool combining multidisciplinary knowledge in informatics, biotechnology, chemistry and biology are essential for optimizing time and reducing costs in the drug design. Thus, the integration of these in silico techniques makes it possible to search for new anti-inflammatory drugs with better pharmacokinetic and toxicological profiles compared to commercially used drugs. This in silico study evaluated the anti-inflammatory potential of two benzoylpropionic acid derivatives (MBPA and DHBPA) using molecular docking and their thermodynamic profiles by molecular dynamics, in addition to predicting oral bioavailability, bioactivity and toxicity. In accordance to our predictions the derivatives proposed here had the potential capacity for COX-2 inhibition in the human and mice enzyme, due to containing similar interactions with the control compound (ibuprofen). Ibuprofen showed toxic predictions of hepatotoxicity (in human, mouse and rat; toxicophoric group 2-arylacetic or 3-arylpropionic acid) and irritation of the gastrointestinal tract (in human, mouse and rat; toxicophoric group alpha-substituted propionic acid or ester) confirming the literature data, as well as the efficiency of the DEREK 10.0.2 program. Moreover, the proposed compounds are predicted to have a good oral bioavailability profile and low toxicity (LD50 < 700 mg/kg) and safety when compared to the commercial compound. Therefore, future studies are necessary to confirm the anti-inflammatory potential of these compounds.
Collapse
Affiliation(s)
- José A H M Bittencourt
- Graduate Program of Pharmaceutical Innovation, Federal University of Amapá, Macapá-AP 68902-280, Brazil.
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá-AP 68902-280, Brazil.
| | - Moysés F A Neto
- Laboratory of Molecular Modeling, State University of Feira de Santana, Feira de Santana-BA 44036-900, Brazil.
| | - Pedro S Lacerda
- Laboratory of Bioinformatics and Molecular Modeling, School of Pharmacy, Federal University of Bahia, Barão de Jeremoabo Street, Salvador 40170-115, BA, Brazil.
| | - Renata C V S Bittencourt
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá-AP 68902-280, Brazil.
| | - Rai C Silva
- Computational Laboratory of Pharmaceutical Chemistry, University of Sao Paulo, Av. Prof. do Café, s/n - Monte Alegre, Ribeirão Preto, São Paulo 14040-903, Brazil.
| | - Cleison C Lobato
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá-AP 68902-280, Brazil.
- Nucleus of Studies and Selection of Bioactive Molecules, Institute of Health Sciences, Federal University of Pará, Belém-PA 66075-110, Brazil.
| | - Luciane B Silva
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá-AP 68902-280, Brazil.
| | - Franco H A Leite
- Laboratory of Molecular Modeling, State University of Feira de Santana, Feira de Santana-BA 44036-900, Brazil.
| | - Juliana P Zuliani
- Laboratory Cellular Immunology Applied to Health, Oswaldo Cruz Foundation, FIOCRUZ Rondônia, Rua da Beira, 7671 BR-364, Porto Velho-RO 78912-000, Brazil.
| | - Joaquín M C Rosa
- Department of Pharmaceutical and Organic Chemistry, Faculty of Pharmacy, Institute of Biosanitary Research ibs.GRANADA. University of Granada, 18071 Granada, Spain.
| | - Rosivaldo S Borges
- Graduate Program of Pharmaceutical Innovation, Federal University of Amapá, Macapá-AP 68902-280, Brazil.
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá-AP 68902-280, Brazil.
- Nucleus of Studies and Selection of Bioactive Molecules, Institute of Health Sciences, Federal University of Pará, Belém-PA 66075-110, Brazil.
| | - Cleydson B R Santos
- Graduate Program of Pharmaceutical Innovation, Federal University of Amapá, Macapá-AP 68902-280, Brazil.
- Laboratory of Modeling and Computational Chemistry, Department of Biological and Health Sciences, Federal University of Amapá, Macapá-AP 68902-280, Brazil.
- Nucleus of Studies and Selection of Bioactive Molecules, Institute of Health Sciences, Federal University of Pará, Belém-PA 66075-110, Brazil.
| |
Collapse
|
16
|
Oliveira CS, Caldeira CAS, Diniz-Sousa R, Romero DL, Marcussi S, Moura LA, Fuly AL, de Carvalho C, Cavalcante WLG, Gallacci M, Pai MD, Zuliani JP, Calderon LA, Soares AM. Pharmacological characterization of cnidarian extracts from the Caribbean Sea: evaluation of anti-snake venom and antitumor properties. J Venom Anim Toxins Incl Trop Dis 2018; 24:22. [PMID: 30181737 PMCID: PMC6114500 DOI: 10.1186/s40409-018-0161-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2017] [Accepted: 08/07/2018] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Cnidarians produce toxins, which are composed of different polypeptides that induce pharmacological effects of biotechnological interest, such as antitumor, antiophidic and anti-clotting activities. This study aimed to evaluate toxicological activities and potential as antitumor and antiophidic agents contained in total extracts from five cnidarians: Millepora alcicornis, Stichodactyla helianthus, Plexaura homomalla, Bartholomea annulata and Condylactis gigantea (total and body wall). METHODS The cnidarian extracts were evaluated by electrophoresis and for their phospholipase, proteolytic, hemorrhagic, coagulant, fibrinogenolytic, neuromuscular blocking, muscle-damaging, edema-inducing and cytotoxic activities. RESULTS All cnidarian extracts showed indirect hemolytic activity, but only S. helianthus induced direct hemolysis and neurotoxic effect. However, the hydrolysis of NBD-PC, a PLA2 substrate, was presented only by the C. gigantea (body wall) and S. helianthus. The extracts from P. homomalla and S. helianthus induced edema, while only C. gigantea and S. helianthus showed intensified myotoxic activity. The proteolytic activity upon casein and fibrinogen was presented mainly by B. annulata extract and all were unable to induce hemorrhage or fibrinogen coagulation. Cnidarian extracts were able to neutralize clotting induced by Bothrops jararacussu snake venom, except M. alcicornis. All cnidarian extracts were able to inhibit hemorrhagic activity induced by Bothrops moojeni venom. Only the C. gigantea (body wall) inhibited thrombin-induced coagulation. All cnidarian extracts showed antitumor effect against Jurkat cells, of which C. gigantea (body wall) and S. helianthus were the most active; however, only C. gigantea (body wall) and M. alcicornis were active against B16F10 cells. CONCLUSION The cnidarian extracts analyzed showed relevant in vitro inhibitory potential over the activities induced by Bothrops venoms; these results may contribute to elucidate the possible mechanisms of interaction between cnidarian extracts and snake venoms.
Collapse
Affiliation(s)
- Cláudia S. Oliveira
- Centro de Estudos de Biomoléculas Aplicadas a Saúde (CEBio), Fundação Oswaldo Cruz de Rondônia (Fiocruz Rondônia), Porto Velho, RO Brazil
- Brazilian Marine Biotechnology Network (BioTecMar Network), Porto Velho, Brazil
- Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO Brazil
| | - Cleópatra A. S. Caldeira
- Centro de Estudos de Biomoléculas Aplicadas a Saúde (CEBio), Fundação Oswaldo Cruz de Rondônia (Fiocruz Rondônia), Porto Velho, RO Brazil
- Brazilian Marine Biotechnology Network (BioTecMar Network), Porto Velho, Brazil
- Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO Brazil
| | - Rafaela Diniz-Sousa
- Centro de Estudos de Biomoléculas Aplicadas a Saúde (CEBio), Fundação Oswaldo Cruz de Rondônia (Fiocruz Rondônia), Porto Velho, RO Brazil
- Brazilian Marine Biotechnology Network (BioTecMar Network), Porto Velho, Brazil
- Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO Brazil
| | - Dolores L. Romero
- Centro de Estudios de Proteínas, Facultad de Biología, Universidad de La Habana, Havana, Cuba
| | - Silvana Marcussi
- Departamento de Química, Universidade Federal de Lavras (UFLA), Lavras, MG Brazil
| | - Laura A. Moura
- Departamento de Biologia Celular e Molecular (GCM), Instituto de Biologia, Universidade Federal Fluminense (UFF), Niterói, RJ Brazil
| | - André L. Fuly
- Departamento de Biologia Celular e Molecular (GCM), Instituto de Biologia, Universidade Federal Fluminense (UFF), Niterói, RJ Brazil
| | - Cicília de Carvalho
- Departamento de Farmacologia, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, SP Brazil
| | - Walter L. G. Cavalcante
- Departamento de Farmacologia, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, SP Brazil
- Instituto de Ciências Biológicas, Departamento de Farmacologia, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG Brazil
| | - Márcia Gallacci
- Departamento de Farmacologia, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, SP Brazil
| | - Maeli Dal Pai
- Departamento de Morfologia, Instituto de Biociências, Universidade Estadual Paulista (UNESP), Botucatu, SP Brazil
| | - Juliana P. Zuliani
- Centro de Estudos de Biomoléculas Aplicadas a Saúde (CEBio), Fundação Oswaldo Cruz de Rondônia (Fiocruz Rondônia), Porto Velho, RO Brazil
- Brazilian Marine Biotechnology Network (BioTecMar Network), Porto Velho, Brazil
- Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO Brazil
| | - Leonardo A. Calderon
- Centro de Estudos de Biomoléculas Aplicadas a Saúde (CEBio), Fundação Oswaldo Cruz de Rondônia (Fiocruz Rondônia), Porto Velho, RO Brazil
- Brazilian Marine Biotechnology Network (BioTecMar Network), Porto Velho, Brazil
- Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO Brazil
| | - Andreimar M. Soares
- Centro de Estudos de Biomoléculas Aplicadas a Saúde (CEBio), Fundação Oswaldo Cruz de Rondônia (Fiocruz Rondônia), Porto Velho, RO Brazil
- Brazilian Marine Biotechnology Network (BioTecMar Network), Porto Velho, Brazil
- Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO Brazil
- Centro Universitário São Lucas (UniSL), Porto Velho, RO Brazil
| |
Collapse
|
17
|
Simoes-Silva R, Alfonso J, Gomez A, Holanda RJ, Sobrinho JC, Zaqueo KD, Moreira-Dill LS, Kayano AM, Grabner FP, da Silva SL, Almeida JR, Stabeli RG, Zuliani JP, Soares AM. Snake Venom, A Natural Library of New Potential Therapeutic Molecules: Challenges and Current Perspectives. Curr Pharm Biotechnol 2018; 19:308-335. [DOI: 10.2174/1389201019666180620111025] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2018] [Revised: 06/01/2018] [Accepted: 06/01/2018] [Indexed: 11/22/2022]
Affiliation(s)
- Rodrigo Simoes-Silva
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Jorge Alfonso
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Ana Gomez
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Rudson J. Holanda
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Juliana C. Sobrinho
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Kayena D. Zaqueo
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Leandro S. Moreira-Dill
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Anderson M. Kayano
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Fernando P. Grabner
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Saulo L. da Silva
- Universidad Regional Amazonica IKIAM, Via Muyuna Km 7, Tena, Napo, Ecuador
| | - Jose R. Almeida
- Universidad Regional Amazonica IKIAM, Via Muyuna Km 7, Tena, Napo, Ecuador
| | - Rodrigo G. Stabeli
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Juliana P. Zuliani
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| | - Andreimar M. Soares
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fiocruz Rondonia, FIOCRUZ e Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| |
Collapse
|
18
|
Paloschi MV, Pontes AS, Soares AM, Zuliani JP. An Update on Potential Molecular Mechanisms Underlying the Actions of Snake Venom L-amino Acid Oxidases (LAAOs). Curr Med Chem 2018; 25:2520-2530. [PMID: 29119915 DOI: 10.2174/0929867324666171109114125] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2017] [Revised: 08/01/2017] [Accepted: 09/29/2017] [Indexed: 11/22/2022]
Abstract
BACKGROUND LAAOs (EC 1.4.3.2) are found in concentrations that vary according to each species of snakes; Viperidae, Crotalidae and Elapidae contain 1-9% of this enzyme in their venoms. METHODS This review focuses on an update on molecular mechanisms, platelet activities, antimicrobial, antiprotozoal, induction of apoptosis and inflammatory potential underlying the actions of SVLAAOs. RESULTS Snake venom LAAOs (SV-LAAOs) have become an interesting subject for pharmacological, structural and molecular studies. CONCLUSION Although the mechanisms of action of these enzymes are not well understood they are a subject of a variety of studies, because LAAOs are multifunctional enzymes exhibiting a wide range of pharmacological effects, including the inhibition or induction of platelet aggregation, hemolysis and hemorrhage, in addition to the stimulation of apoptosis, the activation of leukocytes and the formation of edema. Moreover, SV-LAAOs play an important role in bactericidal, cytotoxic, anti-parasitic, anti-tumor, and antiviral activities.
Collapse
Affiliation(s)
- Mauro V Paloschi
- Laboratorio de Imunologia Celular Aplicada a Saude, Fundacao Oswaldo Cruz, FIOCRUZ Rondonia, Porto Velho-RO, Brazil
| | - Adriana S Pontes
- Laboratorio de Imunologia Celular Aplicada a Saude, Fundacao Oswaldo Cruz, FIOCRUZ Rondonia, Porto Velho-RO, Brazil
| | - Andreimar M Soares
- Centro de Estudos de Biomoleculas Aplicadas a Saude (CEBio), Fundacao Oswaldo Cruz, FIOCRUZ Rondonia e Departamento de Medicina, Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil.,Centro Universitario Sao Lucas, UniSL, Porto Velho-RO, Brazil
| | - Juliana P Zuliani
- Laboratorio de Imunologia Celular Aplicada a Saude, Fundacao Oswaldo Cruz, FIOCRUZ Rondonia, Porto Velho-RO, Brazil.,Centro de Estudos de Biomoleculas Aplicadas a Saude (CEBio), Fundacao Oswaldo Cruz, FIOCRUZ Rondonia e Departamento de Medicina, Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil
| |
Collapse
|
19
|
Diniz-Sousa R, Kayano AM, Caldeira CA, Simões-Silva R, Monteiro MC, Moreira-Dill LS, Grabner FP, Calderon LA, Zuliani JP, Stábeli RG, Soares AM. Biochemical characterization of a phospholipase A 2 homologue from the venom of the social wasp Polybia occidentalis. J Venom Anim Toxins Incl Trop Dis 2018; 24:5. [PMID: 29467796 PMCID: PMC5815181 DOI: 10.1186/s40409-018-0143-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2017] [Accepted: 01/19/2018] [Indexed: 12/28/2022] Open
Abstract
Background Wasp venoms constitute a molecular reservoir of new pharmacological substances such as peptides and proteins, biological property holders, many of which are yet to be identified. Exploring these sources may lead to the discovery of molecules hitherto unknown. This study describes, for the first time in hymenopteran venoms, the identification of an enzymatically inactive phospholipase A2 (PLA2) from the venom of the social wasp Polybia occidentalis. Methods P. occidentalis venom was fractioned by molecular exclusion and reverse phase chromatography. For the biochemical characterization of the protein, 1D and 2D SDS-PAGE were performed, along with phospholipase activity assays on synthetic substrates, MALDI-TOF mass spectrometry and sequencing by Edman degradation. Results The protein, called PocTX, was isolated using two chromatographic steps. Based on the phospholipase activity assay, electrophoresis and mass spectrometry, the protein presented a high degree of purity, with a mass of 13,896.47 Da and a basic pI. After sequencing by the Edman degradation method, it was found that the protein showed a high identity with snake venom PLA2 homologues. Conclusion This is the first report of an enzymatically inactive PLA2 isolated from wasp venom, similar to snake PLA2 homologues.
Collapse
Affiliation(s)
- Rafaela Diniz-Sousa
- Center for the Study of Biomolecules Applicable to Health (CEBio), Oswaldo Cruz Foundation - Rondônia (Fiocruz - Rondônia), Porto Velho, RO Brazil.,2Department of Medicine, Federal University of Rondônia (UNIR), Porto Velho, RO Brazil.,3Postgraduate Program in Experimental Biology (PGBIOEXP), Federal University of Rondônia (UNIR), Porto Velho, RO Brazil.,São Lucas University Center (UniSL), Porto Velho, RO Brazil
| | - Anderson M Kayano
- Center for the Study of Biomolecules Applicable to Health (CEBio), Oswaldo Cruz Foundation - Rondônia (Fiocruz - Rondônia), Porto Velho, RO Brazil.,2Department of Medicine, Federal University of Rondônia (UNIR), Porto Velho, RO Brazil
| | - Cleópatra A Caldeira
- Center for the Study of Biomolecules Applicable to Health (CEBio), Oswaldo Cruz Foundation - Rondônia (Fiocruz - Rondônia), Porto Velho, RO Brazil.,2Department of Medicine, Federal University of Rondônia (UNIR), Porto Velho, RO Brazil.,5Postgraduate Program in Biodiversity and Biotechnology, Bionorte Network, Federal University of Rondônia (UNIR), Porto Velho, RO Brazil
| | - Rodrigo Simões-Silva
- Center for the Study of Biomolecules Applicable to Health (CEBio), Oswaldo Cruz Foundation - Rondônia (Fiocruz - Rondônia), Porto Velho, RO Brazil.,2Department of Medicine, Federal University of Rondônia (UNIR), Porto Velho, RO Brazil
| | - Marta C Monteiro
- 6School of Pharmacy, Federal University of Pará (UFPA), Belém, PA Brazil
| | - Leandro S Moreira-Dill
- Center for the Study of Biomolecules Applicable to Health (CEBio), Oswaldo Cruz Foundation - Rondônia (Fiocruz - Rondônia), Porto Velho, RO Brazil.,2Department of Medicine, Federal University of Rondônia (UNIR), Porto Velho, RO Brazil
| | - Fernando P Grabner
- Center for the Study of Biomolecules Applicable to Health (CEBio), Oswaldo Cruz Foundation - Rondônia (Fiocruz - Rondônia), Porto Velho, RO Brazil.,São Lucas University Center (UniSL), Porto Velho, RO Brazil
| | - Leonardo A Calderon
- Center for the Study of Biomolecules Applicable to Health (CEBio), Oswaldo Cruz Foundation - Rondônia (Fiocruz - Rondônia), Porto Velho, RO Brazil.,2Department of Medicine, Federal University of Rondônia (UNIR), Porto Velho, RO Brazil
| | - Juliana P Zuliani
- Center for the Study of Biomolecules Applicable to Health (CEBio), Oswaldo Cruz Foundation - Rondônia (Fiocruz - Rondônia), Porto Velho, RO Brazil.,2Department of Medicine, Federal University of Rondônia (UNIR), Porto Velho, RO Brazil
| | - Rodrigo G Stábeli
- Center for the Study of Biomolecules Applicable to Health (CEBio), Oswaldo Cruz Foundation - Rondônia (Fiocruz - Rondônia), Porto Velho, RO Brazil.,7Department of Medicine, UFSCar, São Carlos, Center of Translational Medicine, Fiocruz - SP, and School of Medicine of Ribeirão Preto, University of São Paulo (USP), São Paulo, Brazil
| | - Andreimar M Soares
- Center for the Study of Biomolecules Applicable to Health (CEBio), Oswaldo Cruz Foundation - Rondônia (Fiocruz - Rondônia), Porto Velho, RO Brazil.,2Department of Medicine, Federal University of Rondônia (UNIR), Porto Velho, RO Brazil.,São Lucas University Center (UniSL), Porto Velho, RO Brazil
| |
Collapse
|
20
|
Sobrinho JC, Kayano AM, Simões-Silva R, Alfonso JJ, Gomez AF, Gomez MCV, Zanchi FB, Moura LA, Souza VR, Fuly AL, de Oliveira E, da Silva SL, Almeida JR, Zuliani JP, Soares AM. Anti-platelet aggregation activity of two novel acidic Asp49-phospholipases A2 from Bothrops brazili snake venom. Int J Biol Macromol 2018; 107:1014-1022. [DOI: 10.1016/j.ijbiomac.2017.09.069] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2017] [Revised: 09/16/2017] [Accepted: 09/18/2017] [Indexed: 10/18/2022]
|
21
|
Diniz-Sousa R, Caldeira CAS, Kayano AM, Paloschi MV, Pimenta DC, Simões-Silva R, Ferreira AS, Zanchi FB, Matos NB, Grabner FP, Calderon LA, Zuliani JP, Soares AM. Identification of the Molecular Determinants of the Antibacterial Activity of LmutTX, a Lys49 Phospholipase A2
Homologue Isolated from Lachesis muta muta
Snake Venom (Linnaeus, 1766). Basic Clin Pharmacol Toxicol 2017; 122:413-423. [DOI: 10.1111/bcpt.12921] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2017] [Accepted: 10/10/2017] [Indexed: 12/18/2022]
Affiliation(s)
- Rafaela Diniz-Sousa
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Experimental Biology Posgraduate Program (PGBIOEXP); Federal University of Rondonia (UNIR); Porto Velho RO Brazil
| | - Cleópatra A. S. Caldeira
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Biodiversity and Biotechnology Posgraduate Program; Rede BIONORTE; Manaus Brazil
| | - Anderson M. Kayano
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
| | - Mauro V. Paloschi
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Experimental Biology Posgraduate Program (PGBIOEXP); Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Laboratory of Cellular Immunology Applied to Heath; Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
| | - Daniel. C. Pimenta
- Biochemistry and Biophysics Laboratory; Butantan Institute; Sao Paulo SP Brazil
| | - Rodrigo Simões-Silva
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
| | - Amália S. Ferreira
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
| | - Fernando B. Zanchi
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Experimental Biology Posgraduate Program (PGBIOEXP); Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Biodiversity and Biotechnology Posgraduate Program; Rede BIONORTE; Manaus Brazil
| | - Najla B. Matos
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Experimental Biology Posgraduate Program (PGBIOEXP); Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Microbiology Laboratory; Research Center on Tropical Medicine of Rondonia (CEPEM); Porto Velho RO Brazil
- Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
| | | | - Leonardo A. Calderon
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Experimental Biology Posgraduate Program (PGBIOEXP); Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Biodiversity and Biotechnology Posgraduate Program; Rede BIONORTE; Manaus Brazil
| | - Juliana P. Zuliani
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Experimental Biology Posgraduate Program (PGBIOEXP); Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Biodiversity and Biotechnology Posgraduate Program; Rede BIONORTE; Manaus Brazil
- Laboratory of Cellular Immunology Applied to Heath; Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
| | - Andreimar M. Soares
- Center for the Study of Biomolecules Applied to Heath (CEBio); Oswaldo Cruz Foundation (FIOCRUZ), Fiocruz Rondonia; Porto Velho RO Brazil
- Medicine Department; Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Experimental Biology Posgraduate Program (PGBIOEXP); Federal University of Rondonia (UNIR); Porto Velho RO Brazil
- Biodiversity and Biotechnology Posgraduate Program; Rede BIONORTE; Manaus Brazil
- Sao Lucas Universitary Center (UNISL); Porto Velho RO Brazil
| |
Collapse
|
22
|
Xavier CV, da S Setúbal S, Lacouth-Silva F, Pontes AS, Nery NM, de Castro OB, Fernandes CFC, Soares AM, Fortes-Dias CL, Zuliani JP. Phospholipase A 2 Inhibitor from Crotalus durissus terrificus rattlesnake: Effects on human peripheral blood mononuclear cells and human neutrophils cells. Int J Biol Macromol 2017; 105:1117-1125. [PMID: 28743568 DOI: 10.1016/j.ijbiomac.2017.07.140] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2017] [Revised: 07/12/2017] [Accepted: 07/13/2017] [Indexed: 12/20/2022]
Abstract
Crotalus Neutralizing Factor (CNF) is an inhibitor of phospholipase A2 (PLA2), present in the blood plasma of Crotalus durissus terrificus snake. This inhibitor neutralizes the lethal and enzymatic activity of crotoxin, the main neurotoxin from this venom. In this study, we investigated the effects of CNF on the functionality of human peripheral blood mononuclear cells (PBMCs) and human neutrophils. The following parameters were evaluated: viability and proliferation, chemotaxis, cytokines and LTB4 production, cytosolic PLA2s activity, myeloperoxidase (MPO) and superoxide anion (O2-) production. CNF showed no toxicity on PBMCs or neutrophils, and acts by stimulating the release of TNF-α and LTB4, but neither stimulates IL-10 and IL-2 nor affects PBMCs proliferation and O2- release. In neutrophils, CNF induces chemotaxis but does not induce the release of both MPO and O2-. However, it induces LTB4 and IL-8 production. These data show the influence of CNF on PBMCs' function by inducing TNF-α and LTB4 production, and on neutrophils, by stimulating chemotaxis and LTB4 production, via cytosolic PLA2 activity, and IL-8 release. The inflammatory profile produced by CNF is shown for the first time. Our present results suggest that CNF has a role in activation of leukocytes and exert proinflammatory effects on these cell.
Collapse
Affiliation(s)
- Caroline V Xavier
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Programa de Pós-Graduação em Biologia Experimental, PGBIOEXP, Núcleo de Saúde, NUSAU, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Sulamita da S Setúbal
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Programa de Pós-Graduação em Biologia Experimental, PGBIOEXP, Núcleo de Saúde, NUSAU, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Fabianne Lacouth-Silva
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Programa de Pós-Graduação em Biologia Experimental, PGBIOEXP, Núcleo de Saúde, NUSAU, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Adriana S Pontes
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Programa de Pós-Graduação em Biologia Experimental, PGBIOEXP, Núcleo de Saúde, NUSAU, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Neriane M Nery
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Programa de Pós-Graduação em Biologia Experimental, PGBIOEXP, Núcleo de Saúde, NUSAU, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Onassis Boeri de Castro
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Programa de Pós-Graduação em Biologia Experimental, PGBIOEXP, Núcleo de Saúde, NUSAU, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Carla F C Fernandes
- Programa de Pós-Graduação em Biologia Experimental, PGBIOEXP, Núcleo de Saúde, NUSAU, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil; Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil; Centro de Pesquisa em Medicina Tropical (CEPEM), Porto Velho, RO, Brazil
| | - Andreimar M Soares
- Programa de Pós-Graduação em Biologia Experimental, PGBIOEXP, Núcleo de Saúde, NUSAU, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil; Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Consuelo L Fortes-Dias
- Diretoria de Pesquisa e Desenvolvimento, Fundação Ezequiel Dias (FUNED), Belo Horizonte, MG, Brazil
| | - Juliana P Zuliani
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Programa de Pós-Graduação em Biologia Experimental, PGBIOEXP, Núcleo de Saúde, NUSAU, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil; Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.
| |
Collapse
|
23
|
Fernandes CFC, Pereira SDS, Luiz MB, Zuliani JP, Furtado GP, Stabeli RG. Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases. Front Immunol 2017. [PMID: 28649245 PMCID: PMC5465246 DOI: 10.3389/fimmu.2017.00653] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Due mainly to properties such as high affinity and antigen specificity, antibodies have become important tools for biomedical research, diagnosis, and treatment of several human diseases. When the objective is to administer them for therapy, strategies are used to reduce the heterologous protein immunogenicity and to improve pharmacokinetic and pharmacodynamic characteristics. Size minimization contributes to ameliorate these characteristics, while preserving the antigen-antibody interaction site. Since the discovery that camelids produce functional antibodies devoid of light chains, studies have proposed the use of single domains for biosensors, monitoring and treatment of tumors, therapies for inflammatory and neurodegenerative diseases, drug delivery, or passive immunotherapy. Despite an expected increase in antibody and related products in the pharmaceutical market over the next years, few research initiatives are related to the development of alternatives for helping to manage neglected tropical diseases (NTDs). In this review, we summarize developments of camelid single-domain antibodies (VHH) in the field of NTDs. Particular attention is given to VHH-derived products, i.e., VHHs fused to nanoparticles, constructed for the development of rapid diagnostic kits; fused to oligomeric matrix proteins for viral neutralization; and conjugated with proteins for the treatment of human parasites. Moreover, paratransgenesis technology using VHHs is an interesting approach to control parasite development in vectors. With enormous biotechnological versatility, facility and low cost for heterologous production, and greater ability to recognize different epitopes, VHHs have appeared as an opportunity to overcome challenges related to the prevention, detection, and control of human diseases, especially NTDs.
Collapse
Affiliation(s)
| | | | - Marcos B Luiz
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho, Rondônia, Brazil
| | - Juliana P Zuliani
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho, Rondônia, Brazil.,Departamento de Medicina da Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil
| | | | - Rodrigo G Stabeli
- Departamento de Medicina da Universidade Federal de Rondônia, UNIR, Porto Velho, Rondônia, Brazil.,Plataforma Bi-Institucional de Medicina Translacional (Fiocruz-USP), Ribeirão Preto, São Paulo, Brazil
| |
Collapse
|
24
|
Corrêa EA, Kayano AM, Diniz-Sousa R, Setúbal SS, Zanchi FB, Zuliani JP, Matos NB, Almeida JR, Resende LM, Marangoni S, da Silva SL, Soares AM, Calderon LA. Isolation, structural and functional characterization of a new Lys49 phospholipase A2 homologue from Bothrops neuwiedi urutu with bactericidal potential. Toxicon 2016; 115:13-21. [DOI: 10.1016/j.toxicon.2016.02.021] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2015] [Revised: 02/16/2016] [Accepted: 02/24/2016] [Indexed: 11/16/2022]
|
25
|
Pontes AS, Setúbal SDS, Nery NM, da Silva FS, da Silva SD, Fernandes CFC, Stábeli RG, Soares AM, Zuliani JP. p38 MAPK is involved in human neutrophil chemotaxis induced by L-amino acid oxidase from Calloselasma rhodosthoma. Toxicon 2016; 119:106-16. [PMID: 27242041 DOI: 10.1016/j.toxicon.2016.05.013] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2016] [Revised: 04/11/2016] [Accepted: 05/26/2016] [Indexed: 12/12/2022]
Abstract
The action of LAAO, an L-amino acid oxidase isolated from Calloselasma rhodosthoma snake venom, on isolated human neutrophil function was investigated. Cr-LAAO showed no toxicity on neutrophils. Cr-LAAO in its native form induced the neutrophil chemotaxis, suggesting that its primary structure is essential for stimulation the cell. p38 MAPK and PI3K have a role as signaling pathways of CR-LAAO induced chemotaxis. This toxin also induced the production of hydrogen peroxide and stimulated phagocytosis in neutrophils. Furthermore, Cr-LAAO was able to stimulate neutrophils to release IL-6, IL-8, MPO, LTB4 and PGE2. Together, the data showed that the Cr-LAAO triggers relevant proinflammatory events.
Collapse
Affiliation(s)
- Adriana S Pontes
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Sulamita da S Setúbal
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Neriane Monteiro Nery
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil
| | - Francisquinha Souza da Silva
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Faculdade São Lucas, Porto Velho, RO, Brazil
| | - Silvana D da Silva
- Faculdade São Lucas, Porto Velho, RO, Brazil; Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Carla F C Fernandes
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil; Centro de Pesquisa em Medicina Tropical, Porto Velho, RO, Brazil
| | - Rodrigo G Stábeli
- Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Andreimar M Soares
- Faculdade São Lucas, Porto Velho, RO, Brazil; Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Juliana P Zuliani
- Laboratório de Imunologia Celular Aplicada à Saúde, Fundação Oswaldo Cruz, FIOCRUZ Rondônia, Porto Velho, RO, Brazil; Centro de Estudos de Biomoléculas Aplicadas à Saúde (CEBio), Fundação Oswaldo Cruz, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil.
| |
Collapse
|
26
|
Prado NDR, Pereira SS, da Silva MP, Morais MSS, Kayano AM, Moreira-Dill LS, Luiz MB, Zanchi FB, Fuly AL, E. F. Huacca M, Fernandes CF, Calderon LA, Zuliani JP, Pereira da Silva LH, Soares AM, Stabeli RG, F. C. Fernandes C. Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and Isolated Phospholipases A2 by Specific Camelid Single-Domain Antibody Fragments. PLoS One 2016; 11:e0151363. [PMID: 27028872 PMCID: PMC4814101 DOI: 10.1371/journal.pone.0151363] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2015] [Accepted: 02/27/2016] [Indexed: 02/07/2023] Open
Abstract
Antivenoms, produced using animal hyperimmune plasma, remains the standard therapy for snakebites. Although effective against systemic damages, conventional antivenoms have limited efficacy against local tissue damage. Additionally, the hypersensitivity reactions, often elicited by antivenoms, the high costs for animal maintenance, the difficulty of producing homogeneous lots, and the instability of biological products instigate the search for innovative products for antivenom therapy. In this study, camelid antibody fragments (VHH) with specificity to Bothropstoxin I and II (BthTX-I and BthTX-II), two myotoxic phospholipases from Bothrops jararacussu venom, were selected from an immune VHH phage display library. After biopanning, 28 and 6 clones recognized BthTX-I and BthTX-II by ELISA, respectively. Complementarity determining regions (CDRs) and immunoglobulin frameworks (FRs) of 13 VHH-deduced amino acid sequences were identified, as well as the camelid hallmark amino acid substitutions in FR2. Three VHH clones (KF498607, KF498608, and KC329718) were capable of recognizing BthTX-I by Western blot and showed affinity constants in the nanomolar range against both toxins. VHHs inhibited the BthTX-II phospholipase A2 activity, and when tested for cross-reactivity, presented specificity to the Bothrops genus in ELISA. Furthermore, two clones (KC329718 and KF498607) neutralized the myotoxic effects induced by B. jararacussu venom, BthTX-I, BthTX-II, and by a myotoxin from Bothrops brazili venom (MTX-I) in mice. Molecular docking revealed that VHH CDRs are expected to bind the C-terminal of both toxins, essential for myotoxic activity, and to epitopes in the BthTX-II enzymatic cleft. Identified VHHs could be a biotechnological tool to improve the treatment for snake envenomation, an important and neglected world public health problem.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Marcos B. Luiz
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho-RO, Brazil
| | | | - André L. Fuly
- Universidade Federal Fluminense, UFF, Rio de Janeiro-RJ, Brazil
| | | | | | - Leonardo A. Calderon
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho-RO, Brazil
- Universidade Federal de Rondônia, UNIR, Porto Velho-RO, Brazil
| | - Juliana P. Zuliani
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho-RO, Brazil
- Universidade Federal de Rondônia, UNIR, Porto Velho-RO, Brazil
| | | | | | - Rodrigo G. Stabeli
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho-RO, Brazil
- Universidade Federal de Rondônia, UNIR, Porto Velho-RO, Brazil
| | - Carla F. C. Fernandes
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho-RO, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho-RO, Brazil
| |
Collapse
|
27
|
Lacouth-Silva F, Xavier CV, da S. Setúbal S, Pontes AS, Nery NM, de Castro OB, Fernandes CFC, Honda ER, Zanchi FB, Calderon LA, Stábeli RG, Soares AM, Silva-Jardim I, Facundo VA, Zuliani JP. The effect of 3β, 6β, 16β-trihydroxylup-20(29)-ene lupane compound isolated from Combretum leprosum Mart. on peripheral blood mononuclear cells. Altern Ther Health Med 2015; 15:420. [PMID: 26608735 PMCID: PMC4659216 DOI: 10.1186/s12906-015-0948-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2015] [Accepted: 11/21/2015] [Indexed: 01/11/2023]
Abstract
BACKGROUND The Combretum leprosum Mart. plant, popularly known as mofumbo, is used in folk medicine for inflammation, pain and treatment of wounds. From this species, it is possible to isolate three triterpenes: (3β, 6β, 16β-trihydroxylup-20(29)-ene) called lupane, arjunolic acid and molic acid. In this study, through preclinical tests, the effect of lupane was evaluated on the cytotoxicity and on the ability to activate cellular function by the production of TNF-α, an inflammatory cytokine, and IL-10, an immuno regulatory cytokine was assessed. The effect of lupane on the enzymes topoisomerase I and II was also evaluated. METHODS For this reason, peripheral blood mononuclear cells (PBMCs) were obtained and cytotoxicity was assessed by the MTT method at three different times (1, 15 and 24 h), and different concentrations of lupane (0.3, 0.7, 1.5, 6, 3 and 12 μg/mL). The cell function was assessed by the production of TNF-α and IL-10 by PBMCs quantified by specific enzyme immunoassay (ELISA). The activity of topoisomerases was assayed by in vitro biological assays and in silico molecular docking. RESULTS The results obtained showed that lupane at concentrations below 1.5 μg/mL was not toxic to the cells. Moreover, lupane was not able to activate cellular functions and did not alter the production of IL-10 and TNF-α. Furthermore, the data showed that lupane has neither interfered in the action of topoisomerase I nor in the action of topoisomerase II. CONCLUSION Based on preclinical results obtained in this study, we highlight that the compound studied (lupane) has moderate cytotoxicity, does not induce the production of TNF-α and IL-10, and does not act on human topoisomerases. Based on the results of this study and taking into consideration the reports about the anti-inflammatory and leishmanicidal activity of 3β, 6β, 16β-trihydroxylup-20(29)-ene, we suggest that this compound may serve as a biotechnological tool for the treatment of leishmaniasis in the future.
Collapse
|
28
|
Kayano AM, Simões-Silva R, Medeiros PS, Maltarollo VG, Honorio KM, Oliveira E, Albericio F, da Silva SL, Aguiar ACC, Krettli AU, Fernandes CF, Zuliani JP, Calderon LA, Stábeli RG, Soares AM. BbMP-1, a new metalloproteinase isolated from Bothrops brazili snake venom with in vitro antiplasmodial properties. Toxicon 2015; 106:30-41. [DOI: 10.1016/j.toxicon.2015.09.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2015] [Revised: 09/05/2015] [Accepted: 09/07/2015] [Indexed: 10/23/2022]
|
29
|
Guimaraes CLS, Moreira-Dill LS, Fernandes RS, Costa TR, Hage-Melim LIS, Marcussi S, Carvalho BMA, da Silva SL, Zuliani JP, Fernandes CFC, Calderon LA, Soares AM, Stabeli RG. Biodiversity as a source of bioactive compounds against snakebites. Curr Med Chem 2015; 21:2952-79. [PMID: 24164199 DOI: 10.2174/09298673113206660295] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2012] [Revised: 09/17/2013] [Accepted: 10/04/2013] [Indexed: 11/22/2022]
Abstract
Snakebites are a frequently neglected public health issue in tropical and subtropical countries. According to the World Health Organization, 5 million people are bitten annually including up to 2.5 million envenomations. Treatment with antivenom serum remains the only specific therapy for snakebite envenomation. However, it is heterologous and therefore liable to cause adverse reactions, such as early anaphylactic, pyrogenic and delayed reactions. In order to develop alternatives to the current therapy, researchers have been looking for natural products and plant extracts with antimyotoxic, anti-hemorrhagic and anti-inflammatory properties. Especially due to the role the physiopathological processes triggered by snake toxins, play in paralysis, bleeding disorders, kidney failure and tissue damage. Considering the fact that studies involving snake toxins and specific inhibitors, particularly on a molecular level, are the main key to understand neutralization mechanisms and to propose models or prototypes for an alternative therapy, this article presents efforts made by the scientific community in order to produce validated data regarding 87 compounds and plant extracts obtained from 79 species. These plants, which belong to 63 genera and 40 families, have been used by traditional medicine as alternatives or complements to the current serum therapy.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | - Rodrigo G Stabeli
- Centro de Estudos de Biomoleculas Aplicadas a Saude, CEBio, Fundacao Oswaldo Cruz, FIOCRUZ Rondonia, e Departamento de Medicina, Universidade Federal de Rondonia, UNIR, Porto Velho-RO, Brazil.
| |
Collapse
|
30
|
Pereira SS, Moreira-Dill LS, Morais MSS, Prado NDR, Barros ML, Koishi AC, Mazarrotto GACA, Gonçalves GM, Zuliani JP, Calderon LA, Soares AM, Pereira da Silva LH, Duarte dos Santos CN, Fernandes CFC, Stabeli RG. Novel camelid antibody fragments targeting recombinant nucleoprotein of Araucaria hantavirus: a prototype for an early diagnosis of Hantavirus Pulmonary Syndrome. PLoS One 2014; 9:e108067. [PMID: 25243411 PMCID: PMC4171512 DOI: 10.1371/journal.pone.0108067] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2013] [Accepted: 08/25/2014] [Indexed: 01/11/2023] Open
Abstract
In addition to conventional antibodies, camelids produce immunoglobulins G composed exclusively of heavy chains in which the antigen binding site is formed only by single domains called VHH. Their particular characteristics make VHHs interesting tools for drug-delivery, passive immunotherapy and high-throughput diagnosis. Hantaviruses are rodent-borne viruses of the Bunyaviridae family. Two clinical forms of the infection are known. Hemorrhagic Fever with Renal Syndrome (HFRS) is present in the Old World, while Hantavirus Pulmonary Syndrome (HPS) is found on the American continent. There is no specific treatment for HPS and its diagnosis is carried out by molecular or serological techniques, using mainly monoclonal antibodies or hantavirus nucleoprotein (N) to detect IgM and IgG in patient serum. This study proposes the use of camelid VHHs to develop alternative methods for diagnosing and confirming HPS. Phage display technology was employed to obtain VHHs. After immunizing one Lama glama against the recombinant N protein (prNΔ85) of a Brazilian hantavirus strain, VHH regions were isolated to construct an immune library. VHHs were displayed fused to the M13KO7 phage coat protein III and the selection steps were performed on immobilized prNΔ85. After selection, eighty clones recognized specifically the N protein. These were sequenced, grouped based mainly on the CDRs, and five clones were analyzed by western blot (WB), surface plasmon resonance (SPR) device, and ELISA. Besides the ability to recognize prNΔ85 by WB, all selected clones showed affinity constants in the nanomolar range. Additionaly, the clone KC329705 is able to detect prNΔ85 in solution, as well as the native viral antigen. Findings support the hypothesis that selected VHHs could be a powerful tool in the development of rapid and accurate HPS diagnostic assays, which are essential to provide supportive care to patients and reduce the high mortality rate associated with hantavirus infections.
Collapse
Affiliation(s)
| | | | | | | | - Marcos L. Barros
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho, RO, Brazil
| | | | | | | | - Juliana P. Zuliani
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho, RO, Brazil
- Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Leonardo A. Calderon
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho, RO, Brazil
- Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | | | | | | | - Carla F. C. Fernandes
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho, RO, Brazil
- Centro de Pesquisa em Medicina Tropical, CEPEM, Porto Velho, RO, Brazil
- * E-mail: (RGS); (CFCF)
| | - Rodrigo G. Stabeli
- Fundação Oswaldo Cruz, Fiocruz Rondônia, Porto Velho, RO, Brazil
- Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
- * E-mail: (RGS); (CFCF)
| |
Collapse
|
31
|
Izidoro LFM, Sobrinho JC, Mendes MM, Costa TR, Grabner AN, Rodrigues VM, da Silva SL, Zanchi FB, Zuliani JP, Fernandes CFC, Calderon LA, Stábeli RG, Soares AM. Snake venom L-amino acid oxidases: trends in pharmacology and biochemistry. Biomed Res Int 2014; 2014:196754. [PMID: 24738050 PMCID: PMC3971498 DOI: 10.1155/2014/196754] [Citation(s) in RCA: 115] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/20/2013] [Revised: 12/13/2013] [Accepted: 12/16/2013] [Indexed: 11/26/2022]
Abstract
L-amino acid oxidases are enzymes found in several organisms, including venoms of snakes, where they contribute to the toxicity of ophidian envenomation. Their toxicity is primarily due to enzymatic activity, but other mechanisms have been proposed recently which require further investigation. L-amino acid oxidases exert biological and pharmacological effects, including actions on platelet aggregation and the induction of apoptosis, hemorrhage, and cytotoxicity. These proteins present a high biotechnological potential for the development of antimicrobial, antitumor, and antiprotozoan agents. This review provides an overview of the biochemical properties and pharmacological effects of snake venom L-amino acid oxidases, their structure/activity relationship, and supposed mechanisms of action described so far.
Collapse
Affiliation(s)
- Luiz Fernando M. Izidoro
- Faculdade de Ciências Integradas do Pontal e Departamento de Genética e Bioquímica, Universidade Federal de Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Juliana C. Sobrinho
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, (CEBio), Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
| | - Mirian M. Mendes
- Faculdade de Ciências Integradas do Pontal e Departamento de Genética e Bioquímica, Universidade Federal de Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Tássia R. Costa
- Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP), Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil
| | - Amy N. Grabner
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, (CEBio), Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
| | - Veridiana M. Rodrigues
- Faculdade de Ciências Integradas do Pontal e Departamento de Genética e Bioquímica, Universidade Federal de Uberlândia (UFU), Uberlândia, MG, Brazil
| | - Saulo L. da Silva
- Departamento de Química, Biotecnologia e Engenharia de Bioprocessos, Universidade Federal de São João del Rei (UFSJ), Campus Altoparaopeba, Ouro Branco, MG, Brazil
| | - Fernando B. Zanchi
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, (CEBio), Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
| | - Juliana P. Zuliani
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, (CEBio), Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
| | - Carla F. C. Fernandes
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, (CEBio), Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
| | - Leonardo A. Calderon
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, (CEBio), Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
| | - Rodrigo G. Stábeli
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, (CEBio), Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
| | - Andreimar M. Soares
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, (CEBio), Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia (UNIR), Porto Velho, RO, Brazil
| |
Collapse
|
32
|
Calderon LA, Sobrinho JC, Zaqueo KD, de Moura AA, Grabner AN, Mazzi MV, Marcussi S, Nomizo A, Fernandes CFC, Zuliani JP, Carvalho BMA, da Silva SL, Stábeli RG, Soares AM. Antitumoral activity of snake venom proteins: new trends in cancer therapy. Biomed Res Int 2014; 2014:203639. [PMID: 24683541 PMCID: PMC3943284 DOI: 10.1155/2014/203639] [Citation(s) in RCA: 101] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/20/2013] [Revised: 12/07/2013] [Accepted: 12/08/2013] [Indexed: 02/06/2023]
Abstract
For more than half a century, cytotoxic agents have been investigated as a possible treatment for cancer. Research on animal venoms has revealed their high toxicity on tissues and cell cultures, both normal and tumoral. Snake venoms show the highest cytotoxic potential, since ophidian accidents cause a large amount of tissue damage, suggesting a promising utilization of these venoms or their components as antitumoral agents. Over the last few years, we have studied the effects of snake venoms and their isolated enzymes on tumor cell cultures. Some in vivo assays showed antineoplastic activity against induced tumors in mice. In human beings, both the crude venom and isolated enzymes revealed antitumor activities in preliminary assays, with measurable clinical responses in the advanced treatment phase. These enzymes include metalloproteases (MP), disintegrins, L-amino acid oxidases (LAAOs), C-type lectins, and phospholipases A2 (PLA2s). Their mechanisms of action include direct toxic action (PLA2s), free radical generation (LAAOs), apoptosis induction (PLA2s, MP, and LAAOs), and antiangiogenesis (disintegrins and lectins). Higher cytotoxic and cytostatic activities upon tumor cells than normal cells suggest the possibility for clinical applications. Further studies should be conducted to ensure the efficacy and safety of different snake venom compounds for cancer drug development.
Collapse
Affiliation(s)
- Leonardo A. Calderon
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Juliana C. Sobrinho
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Kayena D. Zaqueo
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Andrea A. de Moura
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Amy N. Grabner
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Maurício V. Mazzi
- Fundação Hermínio Ometto, UNIARARAS, Núcleo de Ciências da Saúde-NUCISA, 13607-339 Araras, SP, Brazil
| | - Silvana Marcussi
- Departamento de Química, Universidade Federal de Lavras, UFLA, 37200-000 Lavras, MG, Brazil
| | - Auro Nomizo
- Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, USP, Ribeirão Preto, SP, Brazil
| | - Carla F. C. Fernandes
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Juliana P. Zuliani
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Bruna M. A. Carvalho
- Departamento de Química, Biotecnologia e Engenharia de Bioprocessos, Universidade Federal de São João del Rei, UFSJ, Campus Alto paraopeba, Ouro Branco, MG, Brazil
| | - Saulo L. da Silva
- Departamento de Química, Biotecnologia e Engenharia de Bioprocessos, Universidade Federal de São João del Rei, UFSJ, Campus Alto paraopeba, Ouro Branco, MG, Brazil
| | - Rodrigo G. Stábeli
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| | - Andreimar M. Soares
- Centro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, Fundação Oswaldo Cruz, Fiocruz Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho, RO, Brazil
| |
Collapse
|
33
|
Setúbal SS, Pontes AS, Furtado JL, Xavier CV, Silva FL, Kayano AM, Izidoro LFM, Soares AM, Calderon LA, Stábeli RG, Zuliani JP. Action of two phospholipases A2 purified from Bothrops alternatus snake venom on macrophages. Biochemistry (Mosc) 2013; 78:194-203. [PMID: 23581990 DOI: 10.1134/s0006297913020089] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The in vitro effects of BaltTX-I, a catalytically inactive Lys49 variant of phospholipase A2 (PLA2), and BaltTX-II, an Asp49 catalytically active PLA2 isolated from Bothrops alternatus snake venom, on thioglycollate-elicited macrophages (TG-macrophages) were investigated. At non-cytotoxic concentrations, the secretory PLA2 BaltTX-I but not BaltTX-II stimulated complement receptor-mediated phagocytosis. Pharmacological treatment of TG-macrophages with staurosporine, a protein kinase C (PKC) inhibitor, showed that this kinase is involved in the increase of serum-opsonized zymosan phagocytosis induced by BaltTX-I but not BaltTX-II secretory PLA2, suggesting that PKC may be involved in the stimulatory effect of this toxin in serum-opsonized zymosan phagocytosis. Moreover, BaltTX-I and -II induced superoxide production by TG-macrophages. This superoxide production stimulated by both PLA2s was abolished after treatment of cells with staurosporine, indicating that PKC is an important signaling pathway for the production of this radical. Our experiments showed that, at non-cytotoxic concentrations, BaltTX-I may upregulate phagocytosis via complement receptors, and that both toxins upregulated the respiratory burst in TG-macrophages.
Collapse
Affiliation(s)
- S S Setúbal
- Laboratório de Bioquímica e Biotecnologia e Laboratório de Cultivo Celular e Anticorpos Monoclonais, Instituto de Pesquisas em Patologias Tropicais, Porto Velho, Rondônia, CEP 76812-245, Brazil.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Marcussi S, Stábeli RG, Santos-Filho NA, Menaldo DL, Silva Pereira LL, Zuliani JP, Calderon LA, da Silva SL, Greggi Antunes LM, Soares AM. Genotoxic effect of Bothrops snake venoms and isolated toxins on human lymphocyte DNA. Toxicon 2013; 65:9-14. [DOI: 10.1016/j.toxicon.2012.12.020] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2012] [Revised: 12/18/2012] [Accepted: 12/20/2012] [Indexed: 11/26/2022]
|
35
|
Zuliani JP, Freitas TA, Conceição IM, Kwasniewski FH. Tityus serrulatus venom increases vascular permeability in selected airway tissues in a mast cell-independent way. ACTA ACUST UNITED AC 2013; 65:229-34. [DOI: 10.1016/j.etp.2011.08.010] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2011] [Revised: 07/25/2011] [Accepted: 08/18/2011] [Indexed: 11/24/2022]
|
36
|
Coutinho-Neto A, Caldeira CAS, Souza GHMF, Zaqueo KD, Kayano AM, Silva RS, Zuliani JP, Soares AM, Stábeli RG, Calderon LA. ESI-MS/MS identification of a bradykinin-potentiating peptide from Amazon Bothrops atrox snake venom using a hybrid Qq-oaTOF mass spectrometer. Toxins (Basel) 2013; 5:327-35. [PMID: 23430539 PMCID: PMC3640538 DOI: 10.3390/toxins5020327] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2012] [Revised: 12/13/2012] [Accepted: 12/16/2012] [Indexed: 11/18/2022] Open
Abstract
A bradykinin-potentiating peptide (BPP) from Amazon Bothrops atrox venom with m/z 1384.7386 was identified and characterized by collision induced dissociation (CID) using an ESI-MS/MS spectra obtained in positive ion mode on a hybrid Qq-oaTOF mass spectrometer, Xevo G2 QTof MS (Waters, Manchester, UK). De novo peptide sequence analysis of the CID fragmentation spectra showed the amino acid sequence ZKWPRPGPEIPP, with a pyroglutamic acid and theoretical monoisotopic m/z 1384.7378, which is similar to experimental data, showing a mass accuracy of 0.6 ppm. The peptide is homologous to other BPP from Bothrops moojeni and was named as BPP-BAX12.
Collapse
Affiliation(s)
- Antonio Coutinho-Neto
- Center of Biomolecules Study Applied to Health, Fiocruz Rondônia, Oswaldo Cruz Foundation, Porto Velho, RO 76820-245, Brazil; E-Mails: (A.C.-N.); (C.A.S.C.); (K.D.Z.); (A.M.K.); (R.S.S.); (J.P.Z.); (A.M.S.); (R.G.S.)
| | - Cleópatra A. S. Caldeira
- Center of Biomolecules Study Applied to Health, Fiocruz Rondônia, Oswaldo Cruz Foundation, Porto Velho, RO 76820-245, Brazil; E-Mails: (A.C.-N.); (C.A.S.C.); (K.D.Z.); (A.M.K.); (R.S.S.); (J.P.Z.); (A.M.S.); (R.G.S.)
| | - Gustavo H. M. F. Souza
- MS Applications Development Laboratory, Waters Corporation, Alphaville, SP 06455-020, Brazil; E-Mail:
| | - Kayena D. Zaqueo
- Center of Biomolecules Study Applied to Health, Fiocruz Rondônia, Oswaldo Cruz Foundation, Porto Velho, RO 76820-245, Brazil; E-Mails: (A.C.-N.); (C.A.S.C.); (K.D.Z.); (A.M.K.); (R.S.S.); (J.P.Z.); (A.M.S.); (R.G.S.)
| | - Anderson M. Kayano
- Center of Biomolecules Study Applied to Health, Fiocruz Rondônia, Oswaldo Cruz Foundation, Porto Velho, RO 76820-245, Brazil; E-Mails: (A.C.-N.); (C.A.S.C.); (K.D.Z.); (A.M.K.); (R.S.S.); (J.P.Z.); (A.M.S.); (R.G.S.)
| | - Rodrigo S. Silva
- Center of Biomolecules Study Applied to Health, Fiocruz Rondônia, Oswaldo Cruz Foundation, Porto Velho, RO 76820-245, Brazil; E-Mails: (A.C.-N.); (C.A.S.C.); (K.D.Z.); (A.M.K.); (R.S.S.); (J.P.Z.); (A.M.S.); (R.G.S.)
| | - Juliana P. Zuliani
- Center of Biomolecules Study Applied to Health, Fiocruz Rondônia, Oswaldo Cruz Foundation, Porto Velho, RO 76820-245, Brazil; E-Mails: (A.C.-N.); (C.A.S.C.); (K.D.Z.); (A.M.K.); (R.S.S.); (J.P.Z.); (A.M.S.); (R.G.S.)
- Medicine Department, Federal University of Rondônia, Porto Velho, RO 76801-059, Brazil
| | - Andreimar M. Soares
- Center of Biomolecules Study Applied to Health, Fiocruz Rondônia, Oswaldo Cruz Foundation, Porto Velho, RO 76820-245, Brazil; E-Mails: (A.C.-N.); (C.A.S.C.); (K.D.Z.); (A.M.K.); (R.S.S.); (J.P.Z.); (A.M.S.); (R.G.S.)
| | - Rodrigo G. Stábeli
- Center of Biomolecules Study Applied to Health, Fiocruz Rondônia, Oswaldo Cruz Foundation, Porto Velho, RO 76820-245, Brazil; E-Mails: (A.C.-N.); (C.A.S.C.); (K.D.Z.); (A.M.K.); (R.S.S.); (J.P.Z.); (A.M.S.); (R.G.S.)
- Medicine Department, Federal University of Rondônia, Porto Velho, RO 76801-059, Brazil
| | - Leonardo A. Calderon
- Center of Biomolecules Study Applied to Health, Fiocruz Rondônia, Oswaldo Cruz Foundation, Porto Velho, RO 76820-245, Brazil; E-Mails: (A.C.-N.); (C.A.S.C.); (K.D.Z.); (A.M.K.); (R.S.S.); (J.P.Z.); (A.M.S.); (R.G.S.)
- Medicine Department, Federal University of Rondônia, Porto Velho, RO 76801-059, Brazil
- Author to whom correspondence should be addressed; E-Mail: ; Tel.: +55-6921822118; Fax: +55-6932196000
| |
Collapse
|
37
|
de Souza CAT, Kayano AM, Setúbal SS, Pontes AS, Furtado JL, Kwasniewski FH, Zaqueo KD, Soares AM, Stábeli RG, Zuliani JP. Local and systemic biochemical alterations induced by Bothrops atrox snake venom in mice. J Venom Res 2012; 3:28-34. [PMID: 23487552 PMCID: PMC3595125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/23/2012] [Revised: 10/24/2012] [Accepted: 10/25/2012] [Indexed: 11/15/2022]
Abstract
The local and systemic alterations induced by Bothrops atrox snake venom (BaV) injection in mice were studied. BaV induced superoxide production by migrated neutrophils, mast cell degranulation and phagocytosis by macrophages. Moreover, BaV caused hemorrhage in dorsum of mice after 2hr post- injection. Three hours post-injection in gastrocnemius muscle, we also observed myonecrosis, which was assessed by the determination of serum and tissue CK besides the release of urea, but not creatinine and uric acid, indicating kidney alterations. BaV also induced the release of LDH and transaminases (ALT and AST) indicating tissue and liver abnormalities. In conclusion, the data indicate that BaV induces events of local and systemic importance.
Collapse
Affiliation(s)
- Carlos AT de Souza
- αLaboratório de Bioquímica e Biotecnologia/Cultivo Celular, Instituto de Pesquisas em Patologias Tropicais, IPEPATRO/FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - Anderson M Kayano
- βCentro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho-RO, Brazil
| | - Sulamita S Setúbal
- αLaboratório de Bioquímica e Biotecnologia/Cultivo Celular, Instituto de Pesquisas em Patologias Tropicais, IPEPATRO/FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - Adriana S Pontes
- αLaboratório de Bioquímica e Biotecnologia/Cultivo Celular, Instituto de Pesquisas em Patologias Tropicais, IPEPATRO/FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - Juliana L Furtado
- αLaboratório de Bioquímica e Biotecnologia/Cultivo Celular, Instituto de Pesquisas em Patologias Tropicais, IPEPATRO/FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - Fábio H Kwasniewski
- αLaboratório de Bioquímica e Biotecnologia/Cultivo Celular, Instituto de Pesquisas em Patologias Tropicais, IPEPATRO/FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - Kayena D Zaqueo
- αLaboratório de Bioquímica e Biotecnologia/Cultivo Celular, Instituto de Pesquisas em Patologias Tropicais, IPEPATRO/FIOCRUZ Rondônia, Porto Velho-RO, Brazil
| | - Andreimar M Soares
- βCentro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho-RO, Brazil
| | - Rodrigo G Stábeli
- αLaboratório de Bioquímica e Biotecnologia/Cultivo Celular, Instituto de Pesquisas em Patologias Tropicais, IPEPATRO/FIOCRUZ Rondônia, Porto Velho-RO, Brazil,βCentro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho-RO, Brazil
| | - Juliana P Zuliani
- αLaboratório de Bioquímica e Biotecnologia/Cultivo Celular, Instituto de Pesquisas em Patologias Tropicais, IPEPATRO/FIOCRUZ Rondônia, Porto Velho-RO, Brazil,βCentro de Estudos de Biomoléculas Aplicadas à Saúde, CEBio, FIOCRUZ Rondônia e Departamento de Medicina, Universidade Federal de Rondônia, UNIR, Porto Velho-RO, Brazil,*Correspondence to: Juliana Pavan Zuliani, , , Tel: +55 69 32196010, Fax: 55 69 32196000
| |
Collapse
|
38
|
Teles CBG, Moreira LS, Silva ADAE, Facundo VA, Zuliani JP, Stábeli RG, Silva-Jardim I. Activity of the Lupane isolated from Combretum leprosum against Leishmania amazonensis promastigotes. J BRAZIL CHEM SOC 2011. [DOI: 10.1590/s0103-50532011000500017] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
39
|
Ferreira MGPR, Kayano AM, Silva-Jardim I, Silva TOD, Zuliani JP, Facundo VA, Calderon LDA, Almeida-e-Silva AD, Ciancaglini P, Stábeli RG. Antileishmanial activity of 3-(3,4,5-trimethoxyphenyl) propanoic acid purified from Amazonian Piper tuberculatum Jacq., Piperaceae, fruits. Rev bras farmacogn 2010. [DOI: 10.1590/s0102-695x2010005000033] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
40
|
Zuliani JP, Kayano AM, Zaqueo KD, Neto AC, Sampaio SV, Soares AM, Stabeli RG. Snake venom L-amino acid oxidases: some consideration about their functional characterization. Protein Pept Lett 2009; 16:908-12. [PMID: 19689417 DOI: 10.2174/092986609788923347] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Snake Venom L-amino acid oxidases (LAAOs E.C. 1.4.3.2) are flavoenzymes broadly found in various snake venom compositions. LAAOs have become an attractive subject for molecular biology, biochemistry, physiology and medicine due to their actions on various cells and biological effects on platelets, apoptosis, hemorrhage and others. In this review we try to summarize some of these reports, with special emphasis on apoptosis, anti-protozoa, bactericidal and anti-viral activities.
Collapse
Affiliation(s)
- Juliana P Zuliani
- Laboratório de Bioquímica e Biotecnologia, Instituto de Pesquisas em Patologias Tropicais, Centro de Estudos de Biomoléculas Aplicadas à Medicina, Departamento de Medicina, Universidade Federal de Rondônia, Porto Velho-RO, Brazil
| | | | | | | | | | | | | |
Collapse
|
41
|
Teixeira CFP, Chaves F, Zamunér SR, Fernandes CM, Zuliani JP, Cruz-Hofling MA, Fernandes I, Gutiérrez JM. Effects of neutrophil depletion in the local pathological alterations and muscle regeneration in mice injected with Bothrops jararaca snake venom. Int J Exp Pathol 2005; 86:107-15. [PMID: 15810982 PMCID: PMC2517402 DOI: 10.1111/j.0959-9673.2005.00419.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
Abstract
In order to study the role of neutrophils in the acute local pathological alterations induced by Bothrops jararaca snake venom, and in the process of skeletal muscle regeneration that follows, an experimental model was developed in mice pretreated with either an anti-mouse granulocyte rat monoclonal immunoglobulin G, which induces a profound neutropenia, or an isotype-matched control antibody. B. jararaca venom induced prominent haemorrhage and oedema, but only a moderate myonecrosis. No significant differences were observed in the extent of local haemorrhage, oedema and myonecrosis between neutropenic and control mice, suggesting that neutrophils do not play a determinant role in the acute pathological alterations induced by B. jararaca venom in this experimental model. Moreover, no differences were observed in skeletal muscle regeneration between these two experimental groups. In both the cases, limited areas of myonecrosis were associated with a drastic damage to the microvasculature and a scarce inflammatory infiltrate, with the consequent lack of removal of necrotic debris during the first week, resulting in a poor regenerative response at this time interval. Subsequently, a similar regenerative process occurred in both groups, and by 30 days, necrotic areas were substituted by groups of small regenerating muscle fibres. It is suggested that the drastic effect exerted by B. jararaca venom in the microvasculature precludes an effective access of inflammatory cells to necrotic areas, thereby compromising an effective removal of necrotic debris; this explains the poor regenerative response observed during the first week and the fact that there were no differences between neutropenic and control mice. As neutropenia in this model lasted only 7 days, the successful regenerative process observed at 30 days is associated with revascularization of necrotic regions and with a successful removal by phagocytes of necrotic debris in both groups.
Collapse
Affiliation(s)
| | - Fernando Chaves
- Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa RicaSan José, Costa Rica
| | - Stella R Zamunér
- Laboratorio de Farmacología, Instituto ButantanSao Paulo, Brazil
| | | | | | | | - Irene Fernandes
- Laboratorio de Imunopatología, Instituto ButantanSao Paulo, Brazil
| | - José María Gutiérrez
- Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa RicaSan José, Costa Rica
| |
Collapse
|
42
|
Zuliani JP, Fernandes CM, Zamuner SR, Gutiérrez JM, Teixeira CFP. Inflammatory events induced by Lys-49 and Asp-49 phospholipases A2 isolated from Bothrops asper snake venom: role of catalytic activity. Toxicon 2005; 45:335-46. [PMID: 15683872 DOI: 10.1016/j.toxicon.2004.11.004] [Citation(s) in RCA: 88] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2004] [Revised: 10/27/2004] [Accepted: 11/01/2004] [Indexed: 11/29/2022]
Abstract
The inflammatory events induced in the peritoneal cavity of mice by two PLA2s isolated from Bothrops asper snake venom were investigated. MT-III, an Asp-49 catalytically active enzyme and MT-II, a catalytically inactive Lys-49 variant induced increase in vascular permeability. Inhibition of enzymatic activity of MT-III with p-bromophenacyl bromide reduced this effect. MT-III induced a larger neutrophil infiltrate than MT-II. This activity was significantly reduced after inhibition of catalytic activity. Reduction in the number of neutrophils was observed when antibodies against L-selectin, CD18 or LFA-1 were used, suggesting the involvement of these adhesion molecules in the effects of both PLA2s. There was no effect with antibodies against ICAM-1 and PECAM-1. Increase in the levels of LTB4 and TXA2, as well as of IL-1, IL-6 and TNF-alpha, were observed in the peritoneal exudates induced by MT-III. MT-II did not enhance levels of eicosanoids but increased those of cytokines. It is concluded that both PLA2s induce inflammatory events in this model. Since MT-III exerts a stronger proinflammatory effect, the enzymatic phospholipid hydrolysis may be relevant for these phenomena. However, the fact that MT-II induced inflammation suggests that molecular regions distinct from the catalytic site elicit inflammatory events perhaps by interacting with specific cell membrane acceptors.
Collapse
|
43
|
Silva CA, Zuliani JP, Assakura MT, Mentele R, Camargo ACM, Teixeira CFP, Serrano SMT. Activation of αMβ2-mediated phagocytosis by HF3, a P-III class metalloproteinase isolated from the venom of Bothrops jararaca. Biochem Biophys Res Commun 2004; 322:950-6. [PMID: 15336556 DOI: 10.1016/j.bbrc.2004.08.012] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2004] [Indexed: 11/24/2022]
Abstract
The integrin alpha(M)beta(2) regulates important cell functions in inflammation being the primary phagocytic receptor on macrophages. HF3, a metalloproteinase isolated from Bothrops jararaca venom, is a potent hemorrhagic toxin. A cDNA encoding HF3 indicated that it is a multidomain molecule composed of a pro-domain, a catalytic domain with a zinc binding sequence, followed by disintegrin-like and cysteine-rich domains. It is known that metalloproteinases play a relevant role in the pathogenesis of venom-induced local tissue damage including inflammation. In this study we evaluated the effects of native HF3 and its recombinant disintegrin-like/cysteine-rich domains (DC-HF3) on alpha(M)beta(2)-mediated phagocytosis of opsonized-zymosan particles by macrophages. HF3 and DC-HF3 significantly increased phagocytosis and this activity was inhibited by anti-alpha(M) and anti-beta(2) antibodies. The data show the ability of P-III metalloproteinases to activate macrophages for phagocytosis through integrin alpha(M)beta(2) and suggest that the disintegrin-like/cysteine-rich domains are important for this effect. This is the first report on the activation of phagocytosis via alpha(M)beta(2) integrin by a metalloproteinase containing disintegrin-like/cysteine-rich domains.
Collapse
Affiliation(s)
- Carlos A Silva
- Laboratorio Especial de Toxinologia Aplicada-CAT/CEPID, Instituto Butantan, CEP 05503-900, Sao Paulo, Brazil
| | | | | | | | | | | | | |
Collapse
|
44
|
Teixeira CFP, Zamunér SR, Zuliani JP, Fernandes CM, Cruz-Hofling MA, Fernandes I, Chaves F, Gutiérrez JM. Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected withBothrops aspersnake venom. Muscle Nerve 2003; 28:449-59. [PMID: 14506717 DOI: 10.1002/mus.10453] [Citation(s) in RCA: 151] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Local tissue damage induced by crotaline snake venoms includes edema, myonecrosis, hemorrhage, and an inflammatory response associated with a prominent cellular infiltrate. The role of neutrophils in the local tissue damage induced by Bothrops asper snake venom and by myotoxin I, a phospholipase A2 isolated from this venom, was investigated. Male Swiss mice were pretreated with either an antimouse granulocyte rat monoclonal immunoglobulin G (IgG) antibody or with isotype-matched control antibody. No significant differences in these local effects were observed between mice pretreated with antigranulocyte antibodies and those receiving control IgG. Moreover, myotoxicity induced by B. asper myotoxin I was similar in neutrophil-depleted and control mice. The role of neutrophils in the process of skeletal muscle regeneration was also assessed. Muscle regeneration was assessed by quantifying the muscle levels of creatine kinase and by morphometric histological analysis of the area comprised by regenerating cells in damaged regions of skeletal muscle. Mice depleted of neutrophils and then injected with B. asper venom showed a more deficient regenerative response than mice pretreated with control IgG. Moreover, a drastic difference in the regenerative response was observed in mice injected with myotoxin I, because animals pretreated with control IgG showed a successful regeneration, whereas those depleted of neutrophils had abundant areas of necrotic tissue that had not been removed 7 days after injection, associated with reduced contents of creatine kinase. It is concluded that (1) neutrophils do not play a significant role in the acute local pathological alterations induced by the venom of B. asper, and (2) neutrophils play a prominent role in the process of skeletal muscle regeneration after injection of B. asper venom and myotoxin I, probably related to the phagocytosis of necrotic material and the recruitment of other inflammatory cells, two events directly associated with a successful muscle regenerative response.
Collapse
Affiliation(s)
- C F P Teixeira
- Pharmacology Laboratory, Instituto Butantan, Sao Paulo, Brazil
| | | | | | | | | | | | | | | |
Collapse
|